This is a Validated Antibody Database (VAD) review about human IFN-gamma, based on 362 published articles (read how Labome selects the articles), using IFN-gamma antibody in all methods. It is aimed to help Labome visitors find the most suited IFN-gamma antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
IFN-gamma synonym: IFG; IFI

BioLegend
mouse monoclonal (B27)
  • flow cytometry; human; 1:200; loading ...
BioLegend IFN-gamma antibody (Biolegend, 506516) was used in flow cytometry on human samples at 1:200. bioRxiv (2020) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; human; 1:33; loading ...; fig 2s1
BioLegend IFN-gamma antibody (Biolegend, 502520) was used in flow cytometry on human samples at 1:33 (fig 2s1). elife (2020) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; human; loading ...; fig 4d
BioLegend IFN-gamma antibody (Biolegend, 502516) was used in flow cytometry on human samples (fig 4d). Cell (2020) ncbi
mouse monoclonal (B27)
  • flow cytometry; human; loading ...; fig 5a
BioLegend IFN-gamma antibody (Biolegend, B27) was used in flow cytometry on human samples (fig 5a). Arthritis Res Ther (2020) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; human; fig 2c
BioLegend IFN-gamma antibody (BioLegend, 4S.B3) was used in flow cytometry on human samples (fig 2c). JCI Insight (2020) ncbi
mouse monoclonal (B27)
  • flow cytometry; human; fig 4b
BioLegend IFN-gamma antibody (BioLegend, B27) was used in flow cytometry on human samples (fig 4b). J Immunother Cancer (2020) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; human; loading ...; fig 6d
BioLegend IFN-gamma antibody (BioLegend, 4S.B3) was used in flow cytometry on human samples (fig 6d). Nature (2019) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; human; loading ...; fig 4b
BioLegend IFN-gamma antibody (Biolegend, 502530) was used in flow cytometry on human samples (fig 4b). Cell Mol Gastroenterol Hepatol (2020) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; human; loading ...; fig 1b
BioLegend IFN-gamma antibody (BioLegend, 4SB3) was used in flow cytometry on human samples (fig 1b). J Immunol (2019) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; human; loading ...; fig 6b
BioLegend IFN-gamma antibody (BioLegend, 502536) was used in flow cytometry on human samples (fig 6b). Cell (2019) ncbi
mouse monoclonal (B27)
  • flow cytometry; human; loading ...; fig s11
BioLegend IFN-gamma antibody (BioLegend, 506537) was used in flow cytometry on human samples (fig s11). Cancer Med (2019) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; human; loading ...; fig 3d
BioLegend IFN-gamma antibody (BioLegend, 502520) was used in flow cytometry on human samples (fig 3d). J Exp Med (2019) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; human; loading ...; fig 3b
BioLegend IFN-gamma antibody (Biolegend, 4S.B3) was used in flow cytometry on human samples (fig 3b). Front Immunol (2019) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; human; loading ...; fig 1b
BioLegend IFN-gamma antibody (BioLegend, 502528) was used in flow cytometry on human samples (fig 1b). Immunity (2019) ncbi
mouse monoclonal (B27)
  • flow cytometry; human; loading ...; fig 3b
BioLegend IFN-gamma antibody (BioLegend, B27) was used in flow cytometry on human samples (fig 3b). Infect Immun (2019) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; human; loading ...; fig 1e
BioLegend IFN-gamma antibody (BioLegend, 502542) was used in flow cytometry on human samples (fig 1e). Cell (2019) ncbi
mouse monoclonal (B27)
  • flow cytometry; human; 1:50; loading ...; fig s10c
BioLegend IFN-gamma antibody (Biolegend, B27) was used in flow cytometry on human samples at 1:50 (fig s10c). Nature (2019) ncbi
mouse monoclonal (B27)
  • flow cytometry; human; loading ...; fig 7b
BioLegend IFN-gamma antibody (Biolegend, B27) was used in flow cytometry on human samples (fig 7b). Front Pharmacol (2019) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; human; loading ...; fig 2c
BioLegend IFN-gamma antibody (BioLegend, 4S.B3) was used in flow cytometry on human samples (fig 2c). Nat Immunol (2019) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; human; loading ...; fig 1a
BioLegend IFN-gamma antibody (BioLegend, 4S.B3) was used in flow cytometry on human samples (fig 1a). Immunol Cell Biol (2019) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; human; loading ...; fig 8d
BioLegend IFN-gamma antibody (Biolegend, 4 S.B3) was used in flow cytometry on human samples (fig 8d). Nat Commun (2018) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; human; loading ...; fig s3a
BioLegend IFN-gamma antibody (Biolegend, 4S.B3) was used in flow cytometry on human samples (fig s3a). Proc Natl Acad Sci U S A (2018) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; human; 1:20; loading ...; fig 1a
BioLegend IFN-gamma antibody (Biolegend, 502536) was used in flow cytometry on human samples at 1:20 (fig 1a). Nat Med (2019) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; human; loading ...; fig 1j
BioLegend IFN-gamma antibody (BioLegend, 4S.B3) was used in flow cytometry on human samples (fig 1j). PLoS Pathog (2018) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; human; loading ...; fig 4a
BioLegend IFN-gamma antibody (Biolegend, 502516) was used in flow cytometry on human samples (fig 4a). Cell (2018) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; human; loading ...; fig s3a
BioLegend IFN-gamma antibody (BD Bioscience, 502531) was used in flow cytometry on human samples (fig s3a). J Clin Invest (2018) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; human; loading ...; fig 5d
BioLegend IFN-gamma antibody (BioLegend, 4S.B3) was used in flow cytometry on human samples (fig 5d). Nat Immunol (2018) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; human; loading ...; fig 6a
BioLegend IFN-gamma antibody (BioLegend, 4S.B3) was used in flow cytometry on human samples (fig 6a). Int J Infect Dis (2018) ncbi
mouse monoclonal (B27)
  • flow cytometry; human; loading ...; fig 3f
BioLegend IFN-gamma antibody (Biolegend, B27) was used in flow cytometry on human samples (fig 3f). Proc Natl Acad Sci U S A (2018) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; human; loading ...; fig 3b
BioLegend IFN-gamma antibody (BioLegend, 4S.B3) was used in flow cytometry on human samples (fig 3b). J Exp Med (2018) ncbi
mouse monoclonal (B27)
  • flow cytometry; human; loading ...; fig 2a
BioLegend IFN-gamma antibody (BioLegend, B27) was used in flow cytometry on human samples (fig 2a). Cancer Immunol Res (2018) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; human; loading ...; fig 2i
BioLegend IFN-gamma antibody (BioLegend, 4S.B3) was used in flow cytometry on human samples (fig 2i). J Clin Invest (2018) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; human; loading ...; fig 2c
BioLegend IFN-gamma antibody (BioLegend, 45.B3) was used in flow cytometry on human samples (fig 2c). J Immunol (2018) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; human; loading ...; fig 2b
In order to study the involvement of RANKL in decidual M2 macrophage polarization, BioLegend IFN-gamma antibody (Biolegend, 502511) was used in flow cytometry on human samples (fig 2b). Cell Death Dis (2017) ncbi
mouse monoclonal (B27)
  • flow cytometry; human; fig 1f
BioLegend IFN-gamma antibody (BioLegend, B27) was used in flow cytometry on human samples (fig 1f). Immun Inflamm Dis (2018) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; human; loading ...; fig 3d
BioLegend IFN-gamma antibody (Biolegend, 4S.B3) was used in flow cytometry on human samples (fig 3d). Ann Rheum Dis (2018) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; human; loading ...; fig 5
BioLegend IFN-gamma antibody (BioLegend, 4S.B3) was used in flow cytometry on human samples (fig 5). J Immunol (2017) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; human; loading ...; fig s2a
In order to investigate the effectiveness of a neoantigen vaccine against melanoma, BioLegend IFN-gamma antibody (Biolegend, 4S.B3) was used in flow cytometry on human samples (fig s2a). Nature (2017) ncbi
mouse monoclonal (B27)
  • mass cytometry; human; loading ...; fig 2a
In order to investigate the immune composition of tumor microenvironment in hepatocellular carcinoma, BioLegend IFN-gamma antibody (BioLegend, B27) was used in mass cytometry on human samples (fig 2a). Proc Natl Acad Sci U S A (2017) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; human; loading ...; fig 1a
In order to detail MAIT cell responses to various microorganisms and cytokines, BioLegend IFN-gamma antibody (BioLegend, 4S.B3) was used in flow cytometry on human samples (fig 1a). Proc Natl Acad Sci U S A (2017) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; human; loading ...; fig 4a
BioLegend IFN-gamma antibody (BioLegend, 4S.B3) was used in flow cytometry on human samples (fig 4a). PLoS ONE (2017) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; human; loading ...; fig 1a
BioLegend IFN-gamma antibody (BioLegend, 4S. B3) was used in flow cytometry on human samples (fig 1a). Oncotarget (2017) ncbi
mouse monoclonal (B27)
  • flow cytometry; human; loading ...; fig 3d
In order to evaluate the effectiveness of adoptive natural killer cell therapy against the pulmonary metastasis of Ewing sarcoma, BioLegend IFN-gamma antibody (BioLegend, B27) was used in flow cytometry on human samples (fig 3d). Oncoimmunology (2017) ncbi
mouse monoclonal (B27)
  • flow cytometry; human; loading ...; fig 6b
BioLegend IFN-gamma antibody (BioLegend, B27) was used in flow cytometry on human samples (fig 6b). J Exp Med (2017) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; human; fig 4b
In order to investigate the role of Vgamma9/Vdelta2 T cells in intestinal IL-22 production, BioLegend IFN-gamma antibody (BioLegend, 4S.B3) was used in flow cytometry on human samples (fig 4b). J Immunol (2017) ncbi
mouse monoclonal (B27)
  • flow cytometry; human; loading ...; fig 2a
BioLegend IFN-gamma antibody (BioLegend, 506518) was used in flow cytometry on human samples (fig 2a). Proc Natl Acad Sci U S A (2017) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; human; loading ...; tbl s9
In order to optimize and assess potential malaria vaccine regimens, BioLegend IFN-gamma antibody (BioLegend, 502512) was used in flow cytometry on human samples (tbl s9). Nature (2017) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; human; loading ...
In order to show T cell immunoglobulin and ITIM domain expression increases over time despite early initiation of antiretroviral treatment, BioLegend IFN-gamma antibody (Biolegend, 4S.B3) was used in flow cytometry on human samples . Sci Rep (2017) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; rhesus macaque; loading ...
In order to examine the kinetics of SIV-specific CD8+ T cell cytolytic factor expression in peripheral blood, lymph node, spleen, and gut mucosa from early acute infection through chronic infection, BioLegend IFN-gamma antibody (Biolegend, 4S.B3) was used in flow cytometry on rhesus macaque samples . PLoS Pathog (2016) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; human; loading ...; tbl 1
In order to report the function of CD70-CD27 signaling in patients infected with Epstein-Barr virus, BioLegend IFN-gamma antibody (BioLegend, 4S.B3) was used in flow cytometry on human samples (tbl 1). J Exp Med (2017) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; mouse; loading ...; fig 3d
In order to study the impact of modulating IFN-I signaling during suppressive combined antiretroviral therapy, BioLegend IFN-gamma antibody (BioLegend, 4S.B3) was used in flow cytometry on mouse samples (fig 3d). J Clin Invest (2017) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; human; loading ...; fig 4a
In order to investigate the roles of CD16+ monocytes in T-cell activation and B-cell responses in systemic lupus erythematosus, BioLegend IFN-gamma antibody (Biolegend, 502506) was used in flow cytometry on human samples (fig 4a). Front Immunol (2016) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; human; loading ...; fig 3d
BioLegend IFN-gamma antibody (Biolegend, 502511) was used in flow cytometry on human samples (fig 3d). Cell (2016) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; human; loading ...; fig 3d
BioLegend IFN-gamma antibody (BioLegend, 4S.B3) was used in flow cytometry on human samples (fig 3d). J Exp Med (2016) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; human; fig 2
BioLegend IFN-gamma antibody (Biolegend, 4S.B3) was used in flow cytometry on human samples (fig 2). PLoS Pathog (2016) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; human; loading ...; fig 2e
In order to suggest that the BRD4-p300 signaling cascade promotes antitumor T cell grafts that could be used adoptive immunotherapy, BioLegend IFN-gamma antibody (BioLegend, 4S.B3) was used in flow cytometry on human samples (fig 2e). J Clin Invest (2016) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; human; fig s9d
In order to explore the role of exhausted CD8 positive CXCR5 positive T cells in mice chronically infected with lymphocytic choriomeningitis virus, BioLegend IFN-gamma antibody (Biolegend, 4S.B3) was used in flow cytometry on human samples (fig s9d). Nature (2016) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; human; fig 7
In order to study the functions of WASp knock out natural killer cells, BioLegend IFN-gamma antibody (Biolegend, 502520) was used in flow cytometry on human samples (fig 7). Sci Rep (2016) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; human; loading ...; fig 2a
In order to ask if CD2 is involved in the response of adaptive natural killer cells to HCMV, BioLegend IFN-gamma antibody (BioLegend, 4S.B3) was used in flow cytometry on human samples (fig 2a). Eur J Immunol (2016) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; human; fig s1d
BioLegend IFN-gamma antibody (Biolegend, 4S.B3) was used in flow cytometry on human samples (fig s1d). Eur J Immunol (2016) ncbi
mouse monoclonal (B27)
  • flow cytometry; mouse; loading ...; fig 6g
In order to investigate the contribution of NLRP3 inflammasome activity to the T helper cell 1 response, BioLegend IFN-gamma antibody (BioLegend, B27) was used in flow cytometry on mouse samples (fig 6g). Science (2016) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; human; loading ...; fig 6c
BioLegend IFN-gamma antibody (Biolegend, 4S.B3) was used in flow cytometry on human samples (fig 6c). J Biol Chem (2016) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; mouse; fig 3
BioLegend IFN-gamma antibody (Biolegend, 502530) was used in flow cytometry on mouse samples (fig 3). Oncoimmunology (2016) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; human; loading ...; fig 4b
BioLegend IFN-gamma antibody (BioLegend, 4S.B3) was used in flow cytometry on human samples (fig 4b). Clin Cancer Res (2016) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; human; loading ...; fig 3a
In order to characterize innate lymphoid cell subpopulations isolated from patients with systemic sclerosis, BioLegend IFN-gamma antibody (biolegend, 4S.B3) was used in flow cytometry on human samples (fig 3a). J Immunol (2016) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; human; loading ...; fig 2a
BioLegend IFN-gamma antibody (Biolegend, 4S.B3) was used in flow cytometry on human samples (fig 2a). PLoS Pathog (2016) ncbi
mouse monoclonal (B27)
  • flow cytometry; human; loading ...; fig 4c
In order to examine if pregnancy-related changes in disease activity are associated with changes in T cell populations, BioLegend IFN-gamma antibody (Biolegend, B27) was used in flow cytometry on human samples (fig 4c). Arthritis Res Ther (2016) ncbi
mouse monoclonal (B27)
  • flow cytometry; human; loading ...; fig s2a
In order to study age-related changes in human immunity during a primary virus infection experimentally induced by immunization with live-attenuated yellow fever vaccine, BioLegend IFN-gamma antibody (Biolegend, B27) was used in flow cytometry on human samples (fig s2a). J Immunol (2015) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; human; loading ...; fig 4e
BioLegend IFN-gamma antibody (Biolegend, 4S.B3) was used in flow cytometry on human samples (fig 4e). J Immunol (2015) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; human; fig 1
In order to assess arming of MAIT cell cytolytic antimicrobial activity and induction by IL-7 and faulty in HIV-1 infection, BioLegend IFN-gamma antibody (Biolegend, 4S.B3) was used in flow cytometry on human samples (fig 1). PLoS Pathog (2015) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; human
BioLegend IFN-gamma antibody (BioLegend, 4S . B3) was used in flow cytometry on human samples . Thromb Res (2015) ncbi
mouse monoclonal (B27)
  • immunocytochemistry; human; fig 6
BioLegend IFN-gamma antibody (BioLegend, B27) was used in immunocytochemistry on human samples (fig 6). J Hematol Oncol (2015) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; human; 1:200; fig 6
BioLegend IFN-gamma antibody (Biolegend, 4S.B3) was used in flow cytometry on human samples at 1:200 (fig 6). Nat Commun (2015) ncbi
mouse monoclonal (MD-1)
  • immunohistochemistry - paraffin section; human; fig s4
BioLegend IFN-gamma antibody (BioLegend, MD-1) was used in immunohistochemistry - paraffin section on human samples (fig s4). Mol Cancer (2015) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; human; fig 3
BioLegend IFN-gamma antibody (Biolegend, 502535) was used in flow cytometry on human samples (fig 3). Scand J Immunol (2015) ncbi
mouse monoclonal (B27)
  • flow cytometry; human; loading ...; fig 4c
BioLegend IFN-gamma antibody (Biolegend, B27) was used in flow cytometry on human samples (fig 4c). J Immunol Res (2015) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; human
BioLegend IFN-gamma antibody (Biolegend, 502533) was used in flow cytometry on human samples . Hum Immunol (2015) ncbi
mouse monoclonal (B27)
  • flow cytometry; human; fig 2
BioLegend IFN-gamma antibody (Biolegend, B27) was used in flow cytometry on human samples (fig 2). Cancer Immunol Res (2015) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; human; 2 ul/test
In order to analyze mucosal pinch biopsies collected predominantly during colonoscopies, BioLegend IFN-gamma antibody (Biolegend, 4S.B3) was used in flow cytometry on human samples at 2 ul/test. J Immunol Methods (2015) ncbi
mouse monoclonal (B27)
  • flow cytometry; human; fig 3
BioLegend IFN-gamma antibody (BioLegend, B27) was used in flow cytometry on human samples (fig 3). PLoS ONE (2015) ncbi
mouse monoclonal (MD-1)
  • dot blot; human; tbl s1
In order to use polydimethylsiloxane microchambers to co-detect 42 immune effector proteins secreted from a single LPS-stimulation macrophage, BioLegend IFN-gamma antibody (Biolegend, 507502) was used in dot blot on human samples (tbl s1). Proc Natl Acad Sci U S A (2015) ncbi
mouse monoclonal (B27)
  • flow cytometry; human; fig 4
BioLegend IFN-gamma antibody (Biolegend, B27) was used in flow cytometry on human samples (fig 4). Nat Immunol (2015) ncbi
mouse monoclonal (B27)
  • flow cytometry; human
BioLegend IFN-gamma antibody (Biolegend, B27) was used in flow cytometry on human samples . Eur J Immunol (2015) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; human; 10 mg/ml; fig 3
BioLegend IFN-gamma antibody (BioLegend, 4S.B3) was used in flow cytometry on human samples at 10 mg/ml (fig 3). J Surg Res (2015) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; human
In order to examine the role of TLR7 in HIV-infected CD4 positive T cells, BioLegend IFN-gamma antibody (Biolegend, 4S.B3) was used in flow cytometry on human samples . Nat Immunol (2015) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; human
BioLegend IFN-gamma antibody (BioLegend, 4S.B3) was used in flow cytometry on human samples . J Immunol (2014) ncbi
mouse monoclonal (B27)
  • flow cytometry; human; 1:40
BioLegend IFN-gamma antibody (BioLegend, B27) was used in flow cytometry on human samples at 1:40. Nat Med (2014) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; human; 1:40
BioLegend IFN-gamma antibody (BioLegend, 4S.B3) was used in flow cytometry on human samples at 1:40. Nat Med (2014) ncbi
mouse monoclonal (4S.B3)
BioLegend IFN-gamma antibody (BioLegend, 4S.B3) was used . J Immunol (2014) ncbi
mouse monoclonal (B27)
  • flow cytometry; human; fig 2
BioLegend IFN-gamma antibody (Biolegend, B27) was used in flow cytometry on human samples (fig 2). J Infect Dis (2015) ncbi
mouse monoclonal (4S.B3)
BioLegend IFN-gamma antibody (Biolegend, 4S.B3) was used . PLoS ONE (2014) ncbi
mouse monoclonal (B27)
  • flow cytometry; human; fig 2
BioLegend IFN-gamma antibody (Biolegend, B27) was used in flow cytometry on human samples (fig 2). J Infect Dis (2015) ncbi
mouse monoclonal (4S.B3)
BioLegend IFN-gamma antibody (BioLegend, 4S.B3) was used . J Leukoc Biol (2014) ncbi
mouse monoclonal (B27)
  • flow cytometry; human; fig 5a
BioLegend IFN-gamma antibody (Biolegend, B27) was used in flow cytometry on human samples (fig 5a). J Invest Dermatol (2015) ncbi
mouse monoclonal (NIB42)
  • blocking or activating experiments; human; 10 ug/ml
BioLegend IFN-gamma antibody (Biolegend, NIB42) was used in blocking or activating experiments on human samples at 10 ug/ml. AIDS (2014) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; human
BioLegend IFN-gamma antibody (Biolegend, 4S.B3) was used in flow cytometry on human samples . J Virol (2014) ncbi
mouse monoclonal (4S.B3)
BioLegend IFN-gamma antibody (BioLegend, 4S.B3) was used . Cell Immunol (2014) ncbi
mouse monoclonal (B27)
  • flow cytometry; human
BioLegend IFN-gamma antibody (BioLegend, B27) was used in flow cytometry on human samples . PLoS ONE (2014) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; human; loading ...; fig 1
In order to discuss the importance of assessing immune competence in cancer patients, BioLegend IFN-gamma antibody (Biolegend, 4S.B3) was used in flow cytometry on human samples (fig 1). Cancer Immunol Immunother (2014) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; human
BioLegend IFN-gamma antibody (BioLegend, 4S.B3) was used in flow cytometry on human samples . J Cell Physiol (2014) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; human
BioLegend IFN-gamma antibody (BioLegend, 4S.B3) was used in flow cytometry on human samples . Clin Cancer Res (2013) ncbi
mouse monoclonal (B27)
  • flow cytometry; human
BioLegend IFN-gamma antibody (Biolegend, B27) was used in flow cytometry on human samples . Tuberculosis (Edinb) (2013) ncbi
Invitrogen
mouse monoclonal (4S.B3)
  • flow cytometry; human; loading ...; fig 3e
Invitrogen IFN-gamma antibody (Thermo Fisher Scientific, 11-7319-82) was used in flow cytometry on human samples (fig 3e). Cell (2020) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; human; loading ...; fig s3a
Invitrogen IFN-gamma antibody (Thermo Fisher, 48-7319-42) was used in flow cytometry on human samples (fig s3a). Cell (2020) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; human; loading ...; fig s4a
Invitrogen IFN-gamma antibody (eBioscience, 48-7319-41) was used in flow cytometry on human samples (fig s4a). Cell (2019) ncbi
mouse monoclonal (2G1)
  • other; human; 1:1000; loading ...; fig 4a
Invitrogen IFN-gamma antibody (Thermo Fisher, M700A) was used in other on human samples at 1:1000 (fig 4a). J Exp Med (2019) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; human; loading ...; fig 3a
Invitrogen IFN-gamma antibody (eBioscience, 17-7319-82) was used in flow cytometry on human samples (fig 3a). Cell (2019) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; human; loading ...; fig 5b
Invitrogen IFN-gamma antibody (eBioscience, 4S.B3) was used in flow cytometry on human samples (fig 5b). J Immunol (2019) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; human; loading ...; fig 5f
Invitrogen IFN-gamma antibody (Thermo Fisher, 45-7319-42) was used in flow cytometry on human samples (fig 5f). Cell (2018) ncbi
mouse monoclonal (B27)
  • flow cytometry; human; loading ...; fig s4b
Invitrogen IFN-gamma antibody (eBioscience, B27) was used in flow cytometry on human samples (fig s4b). J Clin Invest (2018) ncbi
mouse monoclonal (B133.5)
  • ELISA; human; loading ...; fig s3c
Invitrogen IFN-gamma antibody (Thermo Fisher Scientific, B133.5) was used in ELISA on human samples (fig s3c). Nat Med (2018) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; human; loading ...; fig 2e
Invitrogen IFN-gamma antibody (eBioscience, 4S.B3) was used in flow cytometry on human samples (fig 2e). J Exp Med (2018) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; human; 1:100; fig 5a
Invitrogen IFN-gamma antibody (eBioscience, 17-7319-41) was used in flow cytometry on human samples at 1:100 (fig 5a). Nat Commun (2018) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; human; fig 2g
Invitrogen IFN-gamma antibody (eBiosciences, 17-7319-82) was used in flow cytometry on human samples (fig 2g). Cell (2018) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; human; fig 6a
Invitrogen IFN-gamma antibody (eBioscience, 4S.B3) was used in flow cytometry on human samples (fig 6a). PLoS ONE (2017) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; human; loading ...; fig s1g
Invitrogen IFN-gamma antibody (eBioscience, 4S.B3) was used in flow cytometry on human samples (fig s1g). J Immunol (2018) ncbi
rat monoclonal (XMG1.2)
  • ELISA; mouse; loading ...; fig 3a
Invitrogen IFN-gamma antibody (Pierce-Thermo Fisher, XMG1.2) was used in ELISA on mouse samples (fig 3a). Infect Immun (2018) ncbi
mouse monoclonal (4S.B3)
  • mass cytometry; human; loading ...; fig s3a
Invitrogen IFN-gamma antibody (eBioscience, 4S.B4) was used in mass cytometry on human samples (fig s3a). Proc Natl Acad Sci U S A (2017) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; human; loading ...; fig s5a
In order to study the the activation of T lymphocyte death by Ebola virus glycoprotein, Invitrogen IFN-gamma antibody (eBiosciences, 12-7319-42) was used in flow cytometry on human samples (fig s5a). PLoS Pathog (2017) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; human; loading ...; fig 4a
Invitrogen IFN-gamma antibody (eBiosciences, 4S.B3) was used in flow cytometry on human samples (fig 4a). J Immunol (2017) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; human; loading ...; fig s2a
In order to investigate lactam-specific T-cell response in the skin and blood of humans, Invitrogen IFN-gamma antibody (eBiosciences, 4S.B3) was used in flow cytometry on human samples (fig s2a). J Allergy Clin Immunol (2018) ncbi
mouse monoclonal (2G1)
  • ELISA; human; 1.5 ug/ml; fig 6a
In order to develop and characterize a functional and de-immunized version of hyperglycosylated interferon alpha, Invitrogen IFN-gamma antibody (Thermo Scientific, 2G1) was used in ELISA on human samples at 1.5 ug/ml (fig 6a). Clin Immunol (2017) ncbi
rat monoclonal (XMG1.2)
  • ELISA; mouse; loading ...; fig s7a
Invitrogen IFN-gamma antibody (eBiosciences, XMG1.2) was used in ELISA on mouse samples (fig s7a). Nat Commun (2016) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; human; loading ...; fig 5a
In order to describe complete autosomal recessive IL-17RA deficiency in patients with chronic mucocutaneous candidiasis, Invitrogen IFN-gamma antibody (Ebiosciences, 4S.B3) was used in flow cytometry on human samples (fig 5a). Proc Natl Acad Sci U S A (2016) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; human; loading ...; fig s3a
In order to characterize gammadelta T cell subsets from healthy humans, Invitrogen IFN-gamma antibody (ebioscience, 4S.B3) was used in flow cytometry on human samples (fig s3a). Proc Natl Acad Sci U S A (2016) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; human; loading ...; fig 3b
Invitrogen IFN-gamma antibody (eBiosciences, 4S.B3) was used in flow cytometry on human samples (fig 3b). PLoS Pathog (2016) ncbi
mouse monoclonal (B133.5)
  • ELISA; human; 1 ug/ml; loading ...; fig 1
In order to discuss the use of an ELISPOT assay to detect IFN-gamma-producing T cells for pretransplant and posttransplant immunological risk stratification, Invitrogen IFN-gamma antibody (Thermo Scientific, M701B) was used in ELISA on human samples at 1 ug/ml (fig 1). Transplant Direct (2016) ncbi
mouse monoclonal (2G1)
  • ELISA; human; 4 ug/ml; loading ...; fig 1
In order to discuss the use of an ELISPOT assay to detect IFN-gamma-producing T cells for pretransplant and posttransplant immunological risk stratification, Invitrogen IFN-gamma antibody (Thermo Scientific, M700A) was used in ELISA on human samples at 4 ug/ml (fig 1). Transplant Direct (2016) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; human; fig s1c
In order to investigate the role of Eomes in the retention of liver natural killer cells, Invitrogen IFN-gamma antibody (eBiosciences, 4S.B3) was used in flow cytometry on human samples (fig s1c). J Immunol (2016) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; human; loading ...; fig 3b
In order to investigate the role of polypyrimidine tract-binding protein 1 in CD4 T cell activation, Invitrogen IFN-gamma antibody (eBioscience, 45B3) was used in flow cytometry on human samples (fig 3b). PLoS ONE (2016) ncbi
mouse monoclonal (B27)
  • flow cytometry; human; loading ...; fig 1a
In order to elucidate the mechanisms by which DRibbles induce T-cell activation, Invitrogen IFN-gamma antibody (Invitrogen, MHCIFG05) was used in flow cytometry on human samples (fig 1a). Cell Death Dis (2016) ncbi
mouse monoclonal (B27)
  • flow cytometry; human; loading ...; fig 4d
In order to study the cytolytic effector capacity of HIV-specific CD8+ T cells, Invitrogen IFN-gamma antibody (Invitrogen, B27) was used in flow cytometry on human samples (fig 4d). PLoS Pathog (2016) ncbi
mouse monoclonal (MD-1)
  • blocking or activating experiments; human; 5 ug/ml; fig 7
Invitrogen IFN-gamma antibody (eBioscience, 14-7317-85) was used in blocking or activating experiments on human samples at 5 ug/ml (fig 7). Nat Commun (2016) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; human; loading ...; fig 4
Invitrogen IFN-gamma antibody (eBioscience, 4S.B3) was used in flow cytometry on human samples (fig 4). J Immunol Res (2016) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; human; loading ...; fig 2e
In order to find predictive markers for patients that will develop gastrointestinal graft-versus-host-disease, Invitrogen IFN-gamma antibody (eBiosciences, 4S.B3) was used in flow cytometry on human samples (fig 2e). JCI Insight (2016) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; human; fig 5
In order to study chronic hepatitis C virus infections and the functional dichotomy of V-delta2 gamma-delta T cells and their role in cytotoxicity and not IFN-gamma production, Invitrogen IFN-gamma antibody (eBioscience, 4S.B3) was used in flow cytometry on human samples (fig 5). Sci Rep (2016) ncbi
mouse monoclonal (4S.B3)
  • mass cytometry; human; loading ...; tbl 1, 3
In order to use elemental metal isotopes conjugated to monoclonal antibodies and study intracellular functional markers and surface phenotypic markers on natural killer cells, Invitrogen IFN-gamma antibody (eBioscience, 4S.B4) was used in mass cytometry on human samples (tbl 1, 3). Methods Mol Biol (2016) ncbi
mouse monoclonal (B27)
  • flow cytometry; human; loading ...; fig 9a
Invitrogen IFN-gamma antibody (Invitrogen, B27) was used in flow cytometry on human samples (fig 9a). PLoS ONE (2016) ncbi
mouse monoclonal (B133.5)
  • ELISA; human; loading ...; fig 6b
In order to discuss the role of myeloid-derived suppressor cells in gliomas, Invitrogen IFN-gamma antibody (Thermo Scientific, M701B) was used in ELISA on human samples (fig 6b). Neuro Oncol (2016) ncbi
mouse monoclonal (2G1)
  • ELISA; human; loading ...; fig 6b
In order to discuss the role of myeloid-derived suppressor cells in gliomas, Invitrogen IFN-gamma antibody (Thermo Scientific, M700A) was used in ELISA on human samples (fig 6b). Neuro Oncol (2016) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; human; loading ...; fig 1a
In order to compare the immune compartmentalization between ileum and colon in healthy and inflamed mucosa, Invitrogen IFN-gamma antibody (e-Bioscience, 4S.B3) was used in flow cytometry on human samples (fig 1a). J Crohns Colitis (2016) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; human; fig 7
In order to determine mucosal characteristics of lymphocytic and collagenous colitis, Invitrogen IFN-gamma antibody (e-Bioscience, 4S.B3) was used in flow cytometry on human samples (fig 7). J Crohns Colitis (2016) ncbi
mouse monoclonal (2G1)
  • ELISA; human; loading ...; fig 4a
In order to examine the contribution of T cells to myasthenia gravis, Invitrogen IFN-gamma antibody (Thermo Scientific, 2G1) was used in ELISA on human samples (fig 4a). J Immunol (2016) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; human; fig 3
Invitrogen IFN-gamma antibody (eBioscience, 12-7319) was used in flow cytometry on human samples (fig 3). Mediators Inflamm (2015) ncbi
mouse monoclonal (350B 10G6)
  • other; human; tbl 1
In order to utilize a homogeneous immunoassay method to identify interferon-gamma in patients with latent tuberculosis infection, Invitrogen IFN-gamma antibody (Invitrogen, AHC4432) was used in other on human samples (tbl 1). J Microbiol Biotechnol (2016) ncbi
mouse monoclonal (67F12A8)
  • other; human; tbl 1
In order to utilize a homogeneous immunoassay method to identify interferon-gamma in patients with latent tuberculosis infection, Invitrogen IFN-gamma antibody (Invitrogen, AHC4539) was used in other on human samples (tbl 1). J Microbiol Biotechnol (2016) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; human; fig 7
Invitrogen IFN-gamma antibody (eBioscience, 4S.B3) was used in flow cytometry on human samples (fig 7). Haematologica (2016) ncbi
mouse monoclonal (2G1)
  • ELISA; human; fig 1
In order to research robust polyfunctional T cell generation and differentiation in patients with advanced ovarian cancer by survivin-targeted immunotherapy, Invitrogen IFN-gamma antibody (Thermo Scientific, M700A) was used in ELISA on human samples (fig 1). Oncoimmunology (2015) ncbi
mouse monoclonal (B133.5)
  • ELISA; human; fig 1
In order to research robust polyfunctional T cell generation and differentiation in patients with advanced ovarian cancer by survivin-targeted immunotherapy, Invitrogen IFN-gamma antibody (Thermo Scientific, M701B) was used in ELISA on human samples (fig 1). Oncoimmunology (2015) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; human; loading ...; fig 2b
In order to examine the effects of immunosuppressive agents on Polyomavirus BKV-specific T cells, Invitrogen IFN-gamma antibody (eBioscience, 4S:P3) was used in flow cytometry on human samples (fig 2b). Kidney Int (2015) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; human; fig s2a
Invitrogen IFN-gamma antibody (eBioscience, 4S.B3) was used in flow cytometry on human samples (fig s2a). Proc Natl Acad Sci U S A (2015) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; human
Invitrogen IFN-gamma antibody (Ebioscience, 4S.B3) was used in flow cytometry on human samples . Clin Immunol (2015) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; human
Invitrogen IFN-gamma antibody (eBioscience, 4S.B3) was used in flow cytometry on human samples . J Immunol (2015) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; human; fig s4
Invitrogen IFN-gamma antibody (eBioscience, 4S.B3) was used in flow cytometry on human samples (fig s4). Infect Immun (2015) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; human
In order to examine the phenotype and function of peripheral gammadelta T cells in patients with chronic hepatitis B during pegylated-interferon-alpha treatment, Invitrogen IFN-gamma antibody (eBioscience, 4S.B3) was used in flow cytometry on human samples . PLoS ONE (2015) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; human; fig 2
Invitrogen IFN-gamma antibody (eBioscience, 4S.B3) was used in flow cytometry on human samples (fig 2). J Immunol (2015) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; human; fig 2
In order to describe the phenotype and functional potential of metastatic differentiated thyroid cancer-associated PD-1 positive T cells, Invitrogen IFN-gamma antibody (eBioscience, 4S.B3) was used in flow cytometry on human samples (fig 2). Cancer Immunol Res (2015) ncbi
mouse monoclonal (4S.B3)
  • dot blot; human; tbl s1
In order to use polydimethylsiloxane microchambers to co-detect 42 immune effector proteins secreted from a single LPS-stimulation macrophage, Invitrogen IFN-gamma antibody (ebioscience, 13- 7319-85) was used in dot blot on human samples (tbl s1). Proc Natl Acad Sci U S A (2015) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; human; fig 2
Invitrogen IFN-gamma antibody (eBioscience, 4S.B3) was used in flow cytometry on human samples (fig 2). J Autoimmun (2015) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; mouse
Invitrogen IFN-gamma antibody (ebioscience, 4S.B3) was used in flow cytometry on mouse samples . Cancer Immunol Res (2015) ncbi
mouse monoclonal (B133.5)
  • ELISA; human; loading ...; fig 2
In order to test if venoms contain CD1-presented antigens, Invitrogen IFN-gamma antibody (Thermo Fisher Scientific, B133.5) was used in ELISA on human samples (fig 2). J Exp Med (2015) ncbi
mouse monoclonal (2G1)
  • ELISA; human; loading ...; fig 2
In order to test if venoms contain CD1-presented antigens, Invitrogen IFN-gamma antibody (Thermo Fisher Scientific, 2G1) was used in ELISA on human samples (fig 2). J Exp Med (2015) ncbi
mouse monoclonal (4S.B3)
  • immunocytochemistry; human
Invitrogen IFN-gamma antibody (eBioscience, 4S.B3) was used in immunocytochemistry on human samples . Autoimmun Rev (2015) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; human; fig s2
Invitrogen IFN-gamma antibody (eBioscience, 45B3) was used in flow cytometry on human samples (fig s2). J Immunol (2015) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; human
Invitrogen IFN-gamma antibody (eBioscience, 4S.B3) was used in flow cytometry on human samples . J Allergy Clin Immunol (2015) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; human
In order to discuss how inflammation contributes to pulmonary arterial hypertension, Invitrogen IFN-gamma antibody (eBioscience, 4S.B3) was used in flow cytometry on human samples . Chest (2015) ncbi
mouse monoclonal (NIB42)
  • blocking or activating experiments; human; 10 ug/ml; fig 1
In order to study autophagy in Mycobacterium tuberculosis-infected patients, Invitrogen IFN-gamma antibody (eBioscience, 16-7318) was used in blocking or activating experiments on human samples at 10 ug/ml (fig 1). Autophagy (2014) ncbi
mouse monoclonal (2G1)
  • ELISA; human
In order to examine the role of TLR7 in HIV-infected CD4 positive T cells, Invitrogen IFN-gamma antibody (Thermo, 2G1) was used in ELISA on human samples . Nat Immunol (2015) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; human
Invitrogen IFN-gamma antibody (eBioscience, 4S.B3) was used in flow cytometry on human samples . PLoS ONE (2014) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; human
Invitrogen IFN-gamma antibody (eBioscience, 4S.B3) was used in flow cytometry on human samples . J Virol (2015) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; human
Invitrogen IFN-gamma antibody (eBioscience, 4S.B3) was used in flow cytometry on human samples . J Immunol (2014) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; human
Invitrogen IFN-gamma antibody (eBioscience, 4S.B3) was used in flow cytometry on human samples . Proc Natl Acad Sci U S A (2014) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; human
Invitrogen IFN-gamma antibody (eBioscience, 4S.B3) was used in flow cytometry on human samples . J Immunol (2014) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; human
Invitrogen IFN-gamma antibody (eBioscience, 4S.B3) was used in flow cytometry on human samples . Clin Cancer Res (2014) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; human
Invitrogen IFN-gamma antibody (eBioscience, 4S.B3) was used in flow cytometry on human samples . FASEB J (2014) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; human
Invitrogen IFN-gamma antibody (eBioscience, 4S.B3) was used in flow cytometry on human samples . Blood (2014) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; human
In order to developed a strategy to expand umbilical cord blood T cells and test their effects after transplantation, Invitrogen IFN-gamma antibody (eBioscience, 4S.B3) was used in flow cytometry on human samples . Leukemia (2015) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; human; loading ...; fig 3a
Invitrogen IFN-gamma antibody (eBioscience, 17-7319-82) was used in flow cytometry on human samples (fig 3a). Oncotarget (2014) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; human; fig 1
Invitrogen IFN-gamma antibody (eBioscience, 4S.B3) was used in flow cytometry on human samples (fig 1). Immunology (2015) ncbi
mouse monoclonal (B27)
  • flow cytometry; rhesus macaque; fig 4
In order to determine if vaccination with a rhesus macaque-derived adenoviral vector simian adenovirus 7 enhances mucosal T cell activation, Invitrogen IFN-gamma antibody (Invitrogen, noca) was used in flow cytometry on rhesus macaque samples (fig 4). J Virol (2014) ncbi
mouse monoclonal (NIB42)
  • blocking or activating experiments; human; 10 ug/ml
In order to investigate the anti-influenza responses of T cell subsets, Invitrogen IFN-gamma antibody (eBioscience, NIB42) was used in blocking or activating experiments on human samples at 10 ug/ml. PLoS ONE (2014) ncbi
mouse monoclonal (B27)
  • flow cytometry; human
In order to study virus-specific human memory T-cell activation in response to Dribble-mediated cross-presentation of viral antigens, Invitrogen IFN-gamma antibody (Invitrogen, MHCIFG05) was used in flow cytometry on human samples . J Transl Med (2014) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; human
Invitrogen IFN-gamma antibody (eBioscience, 4S.B3) was used in flow cytometry on human samples . PLoS Pathog (2014) ncbi
mouse monoclonal (B133.5)
  • ELISA; human
In order to test the effect of different Mycobacterium tuberculosis molecules on HIV-1 replication, Invitrogen IFN-gamma antibody (Thermo scientific, M-701B) was used in ELISA on human samples . PLoS ONE (2013) ncbi
mouse monoclonal (2G1)
  • ELISA; human
In order to test the effect of different Mycobacterium tuberculosis molecules on HIV-1 replication, Invitrogen IFN-gamma antibody (Thermo scientific, M-700A) was used in ELISA on human samples . PLoS ONE (2013) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; human; 1:100
In order to determine the localization of CD4 positive T cells subsets in the healthy intestine, Invitrogen IFN-gamma antibody (eBioscience, 4S.B3) was used in flow cytometry on human samples at 1:100. PLoS ONE (2012) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; human
In order to analyze the regulation of Amphiregulin expression in human T cell subsets, Invitrogen IFN-gamma antibody (eBioscience, 4S.B3) was used in flow cytometry on human samples . PLoS ONE (2012) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; human; fig s1
Invitrogen IFN-gamma antibody (eBioscience, 4S.B3) was used in flow cytometry on human samples (fig s1). PLoS Pathog (2011) ncbi
mouse monoclonal (B-B1)
  • flow cytometry; human; 10 ug/ml; fig 2
In order to elucidate the effect of mycophenolic acid on B cells, Invitrogen IFN-gamma antibody (Invitrogen, clone AHC4032) was used in flow cytometry on human samples at 10 ug/ml (fig 2). J Immunol (2011) ncbi
mouse monoclonal (350B 10G6)
  • blocking or activating experiments; human; 5 ug/ml
In order to examine how antipsychotic drugs affect immune responses, Invitrogen IFN-gamma antibody (Invitrogen, 350B 10G6) was used in blocking or activating experiments on human samples at 5 ug/ml. Immunol Lett (2011) ncbi
mouse monoclonal (NIB42)
  • blocking or activating experiments; human
In order to assess the effect of allogenic mesenchymal stromal cells and skin fibroblasts on natural killer cell function in vitro, Invitrogen IFN-gamma antibody (eBioscience, NIB42) was used in blocking or activating experiments on human samples . Cell Transplant (2011) ncbi
mouse monoclonal (B27)
  • flow cytometry; rhesus macaque; fig 6
In order to investigate changes to macaque NK-cell subsets during infection with SIV, Invitrogen IFN-gamma antibody (Invitrogen, B27) was used in flow cytometry on rhesus macaque samples (fig 6). Blood (2010) ncbi
mouse monoclonal (B27)
  • flow cytometry; human; fig 1
In order to study T regulatory cells in inflamed human liver samples, Invitrogen IFN-gamma antibody (Caltag, MHCIFG05) was used in flow cytometry on human samples (fig 1). J Immunol (2010) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; human; fig 4
In order to show that surface IL-17A is a marker for Th17 cells, Invitrogen IFN-gamma antibody (eBioscience, 4S.B3) was used in flow cytometry on human samples (fig 4). J Immunol (2009) ncbi
mouse monoclonal (GZ-4)
  • flow cytometry; human; tbl 4
In order to use flow cytometry to characterize cells from patients with relapsing-remitting acute or stable multiple sclerosis, Invitrogen IFN-gamma antibody (Caltag, GZ4) was used in flow cytometry on human samples (tbl 4). J Immunol (2009) ncbi
mouse monoclonal (350B 10G6)
  • ELISA; chimpanzee; fig 3
In order to discuss the hurdles involved in human genetic immunization, Invitrogen IFN-gamma antibody (Biosource International, 350B10G6) was used in ELISA on chimpanzee samples (fig 3). PLoS ONE (2008) ncbi
mouse monoclonal (67F12A8)
  • ELISA; chimpanzee; fig 3
In order to discuss the hurdles involved in human genetic immunization, Invitrogen IFN-gamma antibody (Biosource International, 67F12A8) was used in ELISA on chimpanzee samples (fig 3). PLoS ONE (2008) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; human
In order to study the use of DEC-205 targeting in vaccination against Epstein-Barr virus, Invitrogen IFN-gamma antibody (eBioscience, 4S.B3) was used in flow cytometry on human samples . Blood (2008) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; human; fig 3A
In order to quantify the prevalence of Th1 and Th17 cells in the joints of rheumatoid arthritis patients, Invitrogen IFN-gamma antibody (e-Bioscience, 4S.B3) was used in flow cytometry on human samples (fig 3A). Ann Rheum Dis (2008) ncbi
mouse monoclonal (NIB42)
  • blocking or activating experiments; human; 10 ug/ml
In order to study GATA-3 and T-box expression in human T cells, Invitrogen IFN-gamma antibody (eBioscience, NIB42) was used in blocking or activating experiments on human samples at 10 ug/ml. Blood (2007) ncbi
mouse monoclonal (B27)
  • flow cytometry; human
In order to study GATA-3 and T-box expression in human T cells, Invitrogen IFN-gamma antibody (Caltag, B27) was used in flow cytometry on human samples . Blood (2007) ncbi
mouse monoclonal (67F12A8)
  • ELISA; human; fig 3
In order to evaluate the effect of Lactobacillus casei Shirota on human natural killer cell activity, Invitrogen IFN-gamma antibody (Biosource, 67F12A8) was used in ELISA on human samples (fig 3). Clin Exp Immunol (2006) ncbi
mouse monoclonal (350B 10G6)
  • ELISA; human; fig 3
In order to evaluate the effect of Lactobacillus casei Shirota on human natural killer cell activity, Invitrogen IFN-gamma antibody (Biosource, 350B10G6) was used in ELISA on human samples (fig 3). Clin Exp Immunol (2006) ncbi
mouse monoclonal (67F12A8)
  • ELISA; human
In order to analyze the governing of human NK-cell activation by TLR-7 and TLR-8 agonists by distinct indirect pathways, Invitrogen IFN-gamma antibody (BioSource, 67F12A8) was used in ELISA on human samples . Int Immunol (2006) ncbi
mouse monoclonal (67F12A8)
  • ELISA; human; 1:1000
In order to examine the effect of age and inflammation on the induction of Hsp27 in human peripheral blood mononuclear cells, Invitrogen IFN-gamma antibody (Biosource, 67F 12A8) was used in ELISA on human samples at 1:1000. Exp Gerontol (2006) ncbi
mouse monoclonal (350B 10G6)
  • ELISA; human; 1.6 ug/ml
In order to examine the effect of age and inflammation on the induction of Hsp27 in human peripheral blood mononuclear cells, Invitrogen IFN-gamma antibody (Biosource, 350B 10G6) was used in ELISA on human samples at 1.6 ug/ml. Exp Gerontol (2006) ncbi
mouse monoclonal (B27)
  • flow cytometry; human; tbl 2
In order to use flow cytometry to study granzyme A, B, and K expression in human peripheral blood lymphocytes, Invitrogen IFN-gamma antibody (Caltag, B27) was used in flow cytometry on human samples (tbl 2). Eur J Immunol (2005) ncbi
mouse monoclonal (67F12A8)
  • ELISA; human
In order to investigate how early antigen encounters may influence allergy, Invitrogen IFN-gamma antibody (BioSource, 67F12A8) was used in ELISA on human samples . Clin Exp Immunol (2005) ncbi
mouse monoclonal (350B 10G6)
  • ELISA; human
In order to investigate how early antigen encounters may influence allergy, Invitrogen IFN-gamma antibody (BioSource, 350B10G6) was used in ELISA on human samples . Clin Exp Immunol (2005) ncbi
mouse monoclonal (350B 10G6)
  • ELISA; human
In order to report that methylation of the Mycobacterium tuberculosis heparin-binding hemagglutinin is essential for effective T cell immunity to this antigen, Invitrogen IFN-gamma antibody (BioSource, 350B 10G6) was used in ELISA on human samples . Nat Med (2004) ncbi
mouse monoclonal (67F12A8)
  • ELISA; human
In order to report that methylation of the Mycobacterium tuberculosis heparin-binding hemagglutinin is essential for effective T cell immunity to this antigen, Invitrogen IFN-gamma antibody (BioSource, 67F 12A8) was used in ELISA on human samples . Nat Med (2004) ncbi
mouse monoclonal (67F12A8)
  • ELISA; human
In order to investigate epitopes of merozoite surface protein 3, Invitrogen IFN-gamma antibody (Biosource, 67F12A8) was used in ELISA on human samples . J Infect Dis (2004) ncbi
mouse monoclonal (350B 10G6)
  • ELISA; human
In order to investigate epitopes of merozoite surface protein 3, Invitrogen IFN-gamma antibody (Biosource, 350B10G6) was used in ELISA on human samples . J Infect Dis (2004) ncbi
mouse monoclonal (350B 10G6)
  • ELISA; human; 1 ug/ml; tbl 1
In order to explore the immunomodulatory effects of insulin-like growth factor through regulation of cytokine production, Invitrogen IFN-gamma antibody (Biosource, 350B1066) was used in ELISA on human samples at 1 ug/ml (tbl 1). J Leukoc Biol (2004) ncbi
mouse monoclonal (67F12A8)
  • ELISA; human; 0.2 ug/ml; tbl 1
In order to explore the immunomodulatory effects of insulin-like growth factor through regulation of cytokine production, Invitrogen IFN-gamma antibody (Biosource, 67F12A8) was used in ELISA on human samples at 0.2 ug/ml (tbl 1). J Leukoc Biol (2004) ncbi
mouse monoclonal (350B 10G6)
  • ELISA; human; 2.5 ug/ml; fig 1
In order to investigate antibodies produced by patients with alcoholic liver disease, Invitrogen IFN-gamma antibody (Biosource, 350B10G6) was used in ELISA on human samples at 2.5 ug/ml (fig 1). Hepatology (2004) ncbi
mouse monoclonal (67F12A8)
  • ELISA; human; 0.5 ug/ml; fig 1
In order to investigate antibodies produced by patients with alcoholic liver disease, Invitrogen IFN-gamma antibody (Biosource, 67F12A8) was used in ELISA on human samples at 0.5 ug/ml (fig 1). Hepatology (2004) ncbi
mouse monoclonal (350B 10G6)
  • ELISA; human; fig 1
In order to use RT-PCR for the quantification of antigen-induced cytokine mRNA, Invitrogen IFN-gamma antibody (Biosource, clone 350B 10G6) was used in ELISA on human samples (fig 1). J Immunol Methods (2003) ncbi
mouse monoclonal (B27)
  • flow cytometry; human; fig 5
In order to report the adaptive T cell responses to Japanese encephalitis virus in a naturally exposed healthy virus-immune human cohort, Invitrogen IFN-gamma antibody (Caltag, B27) was used in flow cytometry on human samples (fig 5). Arch Virol (2003) ncbi
mouse monoclonal (B133.5)
  • ELISA; human; tbl 1
In order to compare the effect of different immunosuppressive regimens on cytokine expression in the grafted lung, Invitrogen IFN-gamma antibody (Endogen, B133.5) was used in ELISA on human samples (tbl 1). Transplant Proc (2003) ncbi
mouse monoclonal (2G1)
  • ELISA; human; tbl 1
In order to compare the effect of different immunosuppressive regimens on cytokine expression in the grafted lung, Invitrogen IFN-gamma antibody (Endogen, 2G1) was used in ELISA on human samples (tbl 1). Transplant Proc (2003) ncbi
mouse monoclonal (67F12A8)
  • ELISA; human; fig 4
In order to study the immune responses of infants infected with B. pertussis or vaccinated with whole-cell pertussis vaccines, Invitrogen IFN-gamma antibody (BioSource, 67F 12A8) was used in ELISA on human samples (fig 4). J Immunol (2003) ncbi
mouse monoclonal (350B 10G6)
  • ELISA; human; fig 4
In order to study the immune responses of infants infected with B. pertussis or vaccinated with whole-cell pertussis vaccines, Invitrogen IFN-gamma antibody (BioSource, 350B 10G6) was used in ELISA on human samples (fig 4). J Immunol (2003) ncbi
mouse monoclonal (B-B1)
  • flow cytometry; human; 5 ug/ml; fig 1
In order to report an in vitro differentiation assay in which human naive CD4(+) cells are driven toward either the Th1 or Th2 phenotype and study them, Invitrogen IFN-gamma antibody (BioSource, B-B1) was used in flow cytometry on human samples at 5 ug/ml (fig 1). J Immunol (2002) ncbi
rat monoclonal (XMG1.2)
  • ELISA; mouse; fig 7
In order to assess the role of TNF in the formation and maintenance of granulomas, Invitrogen IFN-gamma antibody (Endogen, XMG1.2) was used in ELISA on mouse samples (fig 7). J Immunol (2002) ncbi
mouse monoclonal (67F12A8)
  • ELISA; human; fig 2, 3
In order to examine the effects of co-stimulation by CD58 on the production of Th1-type or Th2 type cytokines, Invitrogen IFN-gamma antibody (Biosource, 67F12A8) was used in ELISA on human samples (fig 2, 3). Int Immunol (2001) ncbi
mouse monoclonal (350B 10G6)
  • ELISA; human; fig 2, 3
In order to examine the effects of co-stimulation by CD58 on the production of Th1-type or Th2 type cytokines, Invitrogen IFN-gamma antibody (Biosource, 350B10G6) was used in ELISA on human samples (fig 2, 3). Int Immunol (2001) ncbi
mouse monoclonal (B-B1)
  • ELISA; human
In order to study immune responses of subepithelial and intraepithelial lymphocytes from human adenoids and tonsils, Invitrogen IFN-gamma antibody (Biosource, B-B1) was used in ELISA on human samples . Am J Pathol (2000) ncbi
mouse monoclonal (350B 10G6)
  • immunohistochemistry - frozen section; human; tbl 3
In order to study intratumor activated natural killer retention and cytokine production, Invitrogen IFN-gamma antibody (Biosource, noca) was used in immunohistochemistry - frozen section on human samples (tbl 3). J Surg Res (1999) ncbi
mouse monoclonal (B27)
  • flow cytometry; human
In order to elucidate the role of A2ARs in the regulation of immune response, Invitrogen IFN-gamma antibody (Caltag, B27) was used in flow cytometry on human samples . Mol Pharmacol (1999) ncbi
mouse monoclonal (67F12A8)
  • ELISA; human
In order to show that cholera toxin inhibits the production of interleukin-12, Invitrogen IFN-gamma antibody (Biosource, AHC4539) was used in ELISA on human samples . J Exp Med (1999) ncbi
mouse monoclonal (350B 10G6)
  • ELISA; human
In order to show that cholera toxin inhibits the production of interleukin-12, Invitrogen IFN-gamma antibody (Biosource, AHC4432) was used in ELISA on human samples . J Exp Med (1999) ncbi
MABTECH
mouse monoclonal (7-B6-1)
  • ELISA; human; 1 ug/ml; loading ...; fig 4c
In order to investigate the effectiveness of a neoantigen vaccine against melanoma, MABTECH IFN-gamma antibody (Mabtech, 7-B6-1) was used in ELISA on human samples at 1 ug/ml (fig 4c). Nature (2017) ncbi
mouse monoclonal (1-D1K)
  • ELISA; human; 2 ug/ml; loading ...; fig 4c
In order to investigate the effectiveness of a neoantigen vaccine against melanoma, MABTECH IFN-gamma antibody (Mabtech, 1-D1K) was used in ELISA on human samples at 2 ug/ml (fig 4c). Nature (2017) ncbi
mouse monoclonal (1-D1K)
  • ELISA; human; loading ...; fig 1a
In order to determine the role of PD-1 in regulating anti-tumor T cell reactivities, MABTECH IFN-gamma antibody (Mabtech, 1D1K) was used in ELISA on human samples (fig 1a). Science (2017) ncbi
mouse monoclonal (1-D1K)
  • ELISA; human; 2 ug/ml; loading ...; fig 6a
In order to study the role of PD-1 and Tim-3 crosstalk in the regulation of antitumor T cell responses, MABTECH IFN-gamma antibody (Mabtech, 3420-2H) was used in ELISA on human samples at 2 ug/ml (fig 6a). Oncoimmunology (2016) ncbi
mouse monoclonal (7-B6-1)
  • ELISA; human; loading ...; fig 4b
MABTECH IFN-gamma antibody (Mabtech, 7-B6-1) was used in ELISA on human samples (fig 4b). Nature (2016) ncbi
mouse monoclonal (1-D1K)
  • ELISA; human; 1 ug/ml; fig 4b
MABTECH IFN-gamma antibody (Mabtech, 1-D1K) was used in ELISA on human samples at 1 ug/ml (fig 4b). Nature (2016) ncbi
Abcam
domestic rabbit polyclonal
  • immunohistochemistry - paraffin section; human; loading ...; fig 2f
Abcam IFN-gamma antibody (Abcam, ab9657) was used in immunohistochemistry - paraffin section on human samples (fig 2f). Aging Cell (2020) ncbi
domestic rabbit polyclonal
  • immunohistochemistry; human; 1:100; loading ...; fig 8m
Abcam IFN-gamma antibody (Abcam, ab25101) was used in immunohistochemistry on human samples at 1:100 (fig 8m). Nat Immunol (2019) ncbi
domestic rabbit polyclonal
  • immunohistochemistry; mouse; 1:100; loading ...; fig 2h
Abcam IFN-gamma antibody (Abcam, ab9657) was used in immunohistochemistry on mouse samples at 1:100 (fig 2h). Nat Commun (2018) ncbi
domestic rabbit monoclonal (EPR1108)
  • immunocytochemistry; mouse; 1:200; loading ...; fig 3e
In order to study the role of CUGBP1 in the profibrotic TGF-beta-dependent activation of hepatic stellate cells, Abcam IFN-gamma antibody (Abcam, ab133566) was used in immunocytochemistry on mouse samples at 1:200 (fig 3e). Nat Commun (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:300; fig 3
In order to assess regulation of angiogenesis in the full-term human placenta and the expression of factors involved that effect in vitro fertilization, Abcam IFN-gamma antibody (Abcam, Ab9657) was used in western blot on human samples at 1:300 (fig 3). Reprod Biol (2016) ncbi
domestic rabbit polyclonal
  • blocking or activating experiments; human; fig s7
In order to elucidate enrichment of oxidized mitochondrial DNA in neutrophil extracellular traps contributes to lupus-like disease, Abcam IFN-gamma antibody (Abcam, ab9657) was used in blocking or activating experiments on human samples (fig s7). Nat Med (2016) ncbi
Santa Cruz Biotechnology
mouse monoclonal (3F1E3)
  • western blot; human; fig 1
Santa Cruz Biotechnology IFN-gamma antibody (Santa Cruz, Sc32813) was used in western blot on human samples (fig 1). J Matern Fetal Neonatal Med (2016) ncbi
mouse monoclonal (G-23)
  • western blot; human; fig 3
Santa Cruz Biotechnology IFN-gamma antibody (Santa Cruz, sc-8423) was used in western blot on human samples (fig 3). PLoS ONE (2015) ncbi
Beckman Coulter
mouse monoclonal (45.15)
  • flow cytometry; human; loading ...; fig 1
Beckman Coulter IFN-gamma antibody (Beckman Coulter, IM2716U) was used in flow cytometry on human samples (fig 1). Exp Ther Med (2017) ncbi
mouse monoclonal (45.15)
  • flow cytometry; human; loading ...; fig 3b
Beckman Coulter IFN-gamma antibody (Beckman Coulter, 45.15) was used in flow cytometry on human samples (fig 3b). PLoS ONE (2016) ncbi
mouse monoclonal (45.15)
  • flow cytometry; human; fig 2B
In order to investigate human T lymphotropic virus type 1 bZIP factor-specific CD4 T cell responses, Beckman Coulter IFN-gamma antibody (Beckman Coulter, 45.15) was used in flow cytometry on human samples (fig 2B). J Immunol (2014) ncbi
BD Biosciences
mouse monoclonal (B27)
  • flow cytometry; human; 3:50; loading ...; fig 4a
BD Biosciences IFN-gamma antibody (BD Biosciences, B27) was used in flow cytometry on human samples at 3:50 (fig 4a). elife (2020) ncbi
mouse monoclonal (B27)
  • flow cytometry; human; 1:100; loading ...; fig 3e
BD Biosciences IFN-gamma antibody (BD Biosciences, B27) was used in flow cytometry on human samples at 1:100 (fig 3e). J Clin Invest (2020) ncbi
mouse monoclonal (B27)
  • flow cytometry; human; loading ...; fig 2a, s1
BD Biosciences IFN-gamma antibody (BD Biosciences, B27) was used in flow cytometry on human samples (fig 2a, s1). Arthritis Res Ther (2020) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; mouse; loading ...; fig s2a
BD Biosciences IFN-gamma antibody (BD Biosciences, 4S.B3) was used in flow cytometry on mouse samples (fig s2a). J Exp Med (2020) ncbi
mouse monoclonal (B27)
  • blocking or activating experiments; human; 10 ng/ml; loading ...; fig 7a
BD Biosciences IFN-gamma antibody (BD Biosciences, 554698) was used in blocking or activating experiments on human samples at 10 ng/ml (fig 7a). elife (2019) ncbi
mouse monoclonal (B27)
  • flow cytometry; human; loading ...; fig 10d
BD Biosciences IFN-gamma antibody (BD Biosciences, 562016) was used in flow cytometry on human samples (fig 10d). Hum Vaccin Immunother (2020) ncbi
mouse monoclonal (B27)
  • flow cytometry; human; loading ...
BD Biosciences IFN-gamma antibody (Pharmingen, B27) was used in flow cytometry on human samples . Front Immunol (2019) ncbi
mouse monoclonal (B27)
  • flow cytometry; human; 1:333; loading ...; fig s6
BD Biosciences IFN-gamma antibody (BD Biosciences, 557643) was used in flow cytometry on human samples at 1:333 (fig s6). Science (2019) ncbi
mouse monoclonal (B27)
  • flow cytometry; human; loading ...; fig 1g
BD Biosciences IFN-gamma antibody (BD Biosciences, 554702) was used in flow cytometry on human samples (fig 1g). Cell (2019) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; human; 1:50; loading ...; fig 1d
BD Biosciences IFN-gamma antibody (BD Biosciences, 4S.B3) was used in flow cytometry on human samples at 1:50 (fig 1d). Gastroenterology (2019) ncbi
mouse monoclonal (B27)
  • flow cytometry; human; loading ...; fig 3a
BD Biosciences IFN-gamma antibody (BD Biosciences, B27) was used in flow cytometry on human samples (fig 3a). Blood (2019) ncbi
mouse monoclonal (B27)
  • flow cytometry; human; loading ...; fig 1b
BD Biosciences IFN-gamma antibody (BD, B27) was used in flow cytometry on human samples (fig 1b). J Virol (2019) ncbi
mouse monoclonal (B27)
  • flow cytometry; human; loading ...; fig 1a
BD Biosciences IFN-gamma antibody (BD, B27) was used in flow cytometry on human samples (fig 1a). J Virol (2019) ncbi
mouse monoclonal (B27)
  • flow cytometry; human; loading ...; fig 1b
BD Biosciences IFN-gamma antibody (BD Biosciences, B27) was used in flow cytometry on human samples (fig 1b). Nat Med (2019) ncbi
mouse monoclonal (B27)
  • flow cytometry; human; loading ...; fig 5b
BD Biosciences IFN-gamma antibody (BD, 554702) was used in flow cytometry on human samples (fig 5b). Cell (2018) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; human; loading ...; fig 2d
BD Biosciences IFN-gamma antibody (BD Biosciences, 554552) was used in flow cytometry on human samples (fig 2d). Cell Rep (2018) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; human; loading ...; fig ex8d
BD Biosciences IFN-gamma antibody (BD Pharmingen, 4S.B3) was used in flow cytometry on human samples (fig ex8d). Nature (2018) ncbi
mouse monoclonal (B27)
  • flow cytometry; human; loading ...; fig s3
BD Biosciences IFN-gamma antibody (BD Biosciences, B27) was used in flow cytometry on human samples (fig s3). J Infect Dis (2019) ncbi
mouse monoclonal (B27)
  • flow cytometry; human; loading ...; fig 2e
BD Biosciences IFN-gamma antibody (BD Biosciences, B27) was used in flow cytometry on human samples (fig 2e). J Infect Dis (2018) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; human; loading ...; fig s8
BD Biosciences IFN-gamma antibody (BD, 4S.B3) was used in flow cytometry on human samples (fig s8). J Clin Invest (2018) ncbi
mouse monoclonal (B27)
  • flow cytometry; human; loading ...; fig s3b
BD Biosciences IFN-gamma antibody (BD Biosciences, B27) was used in flow cytometry on human samples (fig s3b). Int J Hematol (2018) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; human; loading ...; fig 1e
BD Biosciences IFN-gamma antibody (BD Biosciences, 4S.B3) was used in flow cytometry on human samples (fig 1e). J Immunol (2018) ncbi
mouse monoclonal (B27)
  • flow cytometry; human; loading ...; fig 2a
BD Biosciences IFN-gamma antibody (BD, B27) was used in flow cytometry on human samples (fig 2a). J Immunol (2018) ncbi
mouse monoclonal (B27)
  • flow cytometry; human; loading ...; tbl 1
BD Biosciences IFN-gamma antibody (BD Biosciences, 554702) was used in flow cytometry on human samples (tbl 1). J Clin Invest (2018) ncbi
mouse monoclonal (4S.B3)
  • ELISA; human; 1 ug/ml; fig s5o
BD Biosciences IFN-gamma antibody (BD, 4S.B3) was used in ELISA on human samples at 1 ug/ml (fig s5o). J Cell Biol (2018) ncbi
mouse monoclonal (B27)
  • flow cytometry; human; loading ...; fig 6h
BD Biosciences IFN-gamma antibody (BD, B27) was used in flow cytometry on human samples (fig 6h). Cancer Res (2018) ncbi
mouse monoclonal (B27)
  • flow cytometry; human; loading ...; fig 5a
BD Biosciences IFN-gamma antibody (BD Biosciences, 554702) was used in flow cytometry on human samples (fig 5a). Front Immunol (2018) ncbi
mouse monoclonal (B27)
  • flow cytometry; human; loading ...; fig 1f
BD Biosciences IFN-gamma antibody (BD Biosciences, B27) was used in flow cytometry on human samples (fig 1f). Front Immunol (2018) ncbi
mouse monoclonal (B27)
  • flow cytometry; human; loading ...; fig 4a
BD Biosciences IFN-gamma antibody (BD Biosciences, 554702) was used in flow cytometry on human samples (fig 4a). Oncotarget (2018) ncbi
mouse monoclonal (B27)
  • flow cytometry; human; loading ...; fig 6b
BD Biosciences IFN-gamma antibody (BD Biosciences, B27) was used in flow cytometry on human samples (fig 6b). Sci Rep (2018) ncbi
mouse monoclonal (B27)
  • flow cytometry; rhesus macaque; fig 1a
BD Biosciences IFN-gamma antibody (BD Biosciences, 561024) was used in flow cytometry on rhesus macaque samples (fig 1a). Cell (2018) ncbi
mouse monoclonal (B27)
  • flow cytometry; human; fig 3e
BD Biosciences IFN-gamma antibody (BD Biosciences, 554702) was used in flow cytometry on human samples (fig 3e). Cell (2018) ncbi
mouse monoclonal (B27)
  • flow cytometry; human; loading ...; fig s1
BD Biosciences IFN-gamma antibody (BD Biosciences, B27) was used in flow cytometry on human samples (fig s1). PLoS ONE (2017) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; human; loading ...; fig 1a
  • ELISA; human; loading ...; fig 3a
BD Biosciences IFN-gamma antibody (BD, 4S.B3) was used in flow cytometry on human samples (fig 1a) and in ELISA on human samples (fig 3a). J Immunol (2017) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; human; loading ...; fig 3d
BD Biosciences IFN-gamma antibody (BD, 554552) was used in flow cytometry on human samples (fig 3d). J Clin Invest (2017) ncbi
mouse monoclonal (25723.11)
  • flow cytometry; human; fig 5d
In order to generate T cells from cord blood hematopoietic progenitor cells transduced to express an antigen receptor as assess their ability to limit malignant cells and graft versus host disease, BD Biosciences IFN-gamma antibody (BD Biosciences, 340452) was used in flow cytometry on human samples (fig 5d). Oncoimmunology (2017) ncbi
mouse monoclonal (B27)
  • flow cytometry; human; loading ...; fig 4b
BD Biosciences IFN-gamma antibody (BD Bioscience, 559327) was used in flow cytometry on human samples (fig 4b). Oncoimmunology (2017) ncbi
mouse monoclonal (B27)
  • flow cytometry; human; loading ...; fig 5c
In order to find a role for IL-4 in promoting breast cancer aggressiveness, BD Biosciences IFN-gamma antibody (BD Bioscience, B27) was used in flow cytometry on human samples (fig 5c). Cancer Res (2017) ncbi
mouse monoclonal (B27)
  • flow cytometry; rhesus macaque; loading ...; fig 5c
BD Biosciences IFN-gamma antibody (BD Biosciences, B27) was used in flow cytometry on rhesus macaque samples (fig 5c). JCI Insight (2017) ncbi
mouse monoclonal (4S.B3)
  • ELISA; human; loading ...; fig 7b
  • ELISA; mouse; loading ...; fig 5a, 6a
BD Biosciences IFN-gamma antibody (BD, 554550) was used in ELISA on human samples (fig 7b) and in ELISA on mouse samples (fig 5a, 6a). J Immunol (2017) ncbi
mouse monoclonal (B27)
  • flow cytometry; human; loading ...; fig 4c
BD Biosciences IFN-gamma antibody (BD Biosciences, B27) was used in flow cytometry on human samples (fig 4c). J Immunol (2017) ncbi
mouse monoclonal (B27)
  • flow cytometry; human; fig 5
In order to elucidate the effects of pathogen recognition receptors on dendritic cell maturation, HIV infection, and on the quality of HIV-specific cytotoxic T-cell activation, BD Biosciences IFN-gamma antibody (BD, 557995) was used in flow cytometry on human samples (fig 5). Eur J Immunol (2017) ncbi
mouse monoclonal (B27)
  • flow cytometry; mouse; loading ...; fig s6d
In order to assess the effects of targeting the chimeric antigen receptors to the TRAC locus, BD Biosciences IFN-gamma antibody (BD Horizon, B27) was used in flow cytometry on mouse samples (fig s6d). Nature (2017) ncbi
mouse monoclonal (B27)
  • flow cytometry; human; loading ...; fig 6a
In order to use CD49a expression to define subsets of tissue-resident memory T cells in the skin, BD Biosciences IFN-gamma antibody (BD Bioscience, B27) was used in flow cytometry on human samples (fig 6a). Immunity (2017) ncbi
mouse monoclonal (B27)
  • flow cytometry; rhesus macaque; loading ...; fig 3a
In order to study CXCR5+ CD8 T cells in SIV-infected animals, BD Biosciences IFN-gamma antibody (BD Biosciences, B27) was used in flow cytometry on rhesus macaque samples (fig 3a). Proc Natl Acad Sci U S A (2017) ncbi
mouse monoclonal (B27)
  • flow cytometry; human; 1:10; loading ...; fig 2b
BD Biosciences IFN-gamma antibody (BD Biosciences, B27) was used in flow cytometry on human samples at 1:10 (fig 2b). JCI Insight (2017) ncbi
mouse monoclonal (B27)
  • flow cytometry; human; loading ...
In order to show T cell immunoglobulin and ITIM domain expression increases over time despite early initiation of antiretroviral treatment, BD Biosciences IFN-gamma antibody (BD Bioscience, B27) was used in flow cytometry on human samples . Sci Rep (2017) ncbi
mouse monoclonal (B27)
  • flow cytometry; human; loading ...; fig 5a
In order to propose that decidual stromal cells are a cellular source of BAFF for B cells present in decidua during pregnancy, BD Biosciences IFN-gamma antibody (BD Bioscience, 562016) was used in flow cytometry on human samples (fig 5a). Sci Rep (2017) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; rhesus macaque; loading ...; tbl 1
In order to establish the ability of the herpes simplex virus-1 VC2 vaccine to elicit immune responses in rhesus macaques, BD Biosciences IFN-gamma antibody (BD Biosciences, 4S.B3) was used in flow cytometry on rhesus macaque samples (tbl 1). Vaccine (2017) ncbi
mouse monoclonal (B27)
  • flow cytometry; human; loading ...; fig 1a
In order to explore how HIV-1 alters immunity during latent tuberculosis, BD Biosciences IFN-gamma antibody (BD, B27) was used in flow cytometry on human samples (fig 1a). Tuberculosis (Edinb) (2016) ncbi
mouse monoclonal (B27)
  • flow cytometry; rhesus macaque; loading ...; fig 6b
In order to discuss the assessment of species cross-reactive human agents in large animal graft-versus-host disease models, BD Biosciences IFN-gamma antibody (BD Pharmingen, 560371) was used in flow cytometry on rhesus macaque samples (fig 6b). Transplantation (2016) ncbi
mouse monoclonal (B27)
  • flow cytometry; human; fig 2c
In order to evaluate combinations of TLR and C-type lectin receptor agonists on the Th1 responses of newborn dendritic cells, BD Biosciences IFN-gamma antibody (BD Biosciences, B27) was used in flow cytometry on human samples (fig 2c). J Immunol (2016) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; human; loading ...; fig s4b
BD Biosciences IFN-gamma antibody (BD Biosciences, 4S.B3) was used in flow cytometry on human samples (fig s4b). Proc Natl Acad Sci U S A (2016) ncbi
mouse monoclonal (B27)
  • flow cytometry; rhesus macaque; fig 4a
In order to examine the contribution of HIV-derived conserved elements in vaccination, BD Biosciences IFN-gamma antibody (BD Pharmingen, B27) was used in flow cytometry on rhesus macaque samples (fig 4a). J Immunol (2016) ncbi
mouse monoclonal (B27)
  • flow cytometry; human; loading ...; fig 8a
In order to characterize CD8 positive T cell subsets in dengue patients from India and Thailand, BD Biosciences IFN-gamma antibody (BD, 554700) was used in flow cytometry on human samples (fig 8a). J Virol (2016) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; rhesus macaque; loading ...; fig 8b
BD Biosciences IFN-gamma antibody (BD, 552882) was used in flow cytometry on rhesus macaque samples (fig 8b). Sci Rep (2016) ncbi
mouse monoclonal (B27)
  • flow cytometry; human; loading ...; fig s3b
BD Biosciences IFN-gamma antibody (BD Biosciences, 554702) was used in flow cytometry on human samples (fig s3b). Cell (2016) ncbi
mouse monoclonal (B27)
  • flow cytometry; human; loading ...
In order to identify RLTPR in patients and determine the effects of these mutations on CD4 positive T cells, BD Biosciences IFN-gamma antibody (BD, B27) was used in flow cytometry on human samples . J Exp Med (2016) ncbi
mouse monoclonal (B27)
  • flow cytometry; human; loading ...; fig 1a
In order to determine the S. Typhi, S. Paratyphi A, and S. Paratyphi B cross-reactive CD4 positive T cell responses elicited by immunization with Ty21a, BD Biosciences IFN-gamma antibody (BD, B27) was used in flow cytometry on human samples (fig 1a). Clin Immunol (2016) ncbi
mouse monoclonal (B27)
  • flow cytometry; rhesus macaque; loading ...; fig 6d
BD Biosciences IFN-gamma antibody (BD Biosciences, B27) was used in flow cytometry on rhesus macaque samples (fig 6d). Front Immunol (2016) ncbi
mouse monoclonal (B27)
  • flow cytometry; rhesus macaque; loading ...; fig 1b
BD Biosciences IFN-gamma antibody (BD Biosciences, B27) was used in flow cytometry on rhesus macaque samples (fig 1b). J Virol (2016) ncbi
mouse monoclonal (B27)
  • flow cytometry; human; loading ...; fig 2c
BD Biosciences IFN-gamma antibody (Becton-Dickinson, B27) was used in flow cytometry on human samples (fig 2c). J Immunol (2016) ncbi
mouse monoclonal (4S.B3)
  • ELISA; human; loading ...; fig 1
In order to test if soluble CTLA-4 controls autoantigen-specific immunity in a model of systemic lupus erythematosus, BD Biosciences IFN-gamma antibody (BD Biosciences, 4S.B3) was used in ELISA on human samples (fig 1). Arthritis Res Ther (2016) ncbi
mouse monoclonal (B27)
  • flow cytometry; human; fig 1
BD Biosciences IFN-gamma antibody (BD Pharmigen, 557643) was used in flow cytometry on human samples (fig 1). Oncoimmunology (2016) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; human; fig 1
BD Biosciences IFN-gamma antibody (BD Bioscience, 557844) was used in flow cytometry on human samples (fig 1). Oncoimmunology (2016) ncbi
mouse monoclonal (B27)
  • flow cytometry; human; loading ...; fig 6c
In order to report that IgA-producing plasma cells are a major source of inducible NO synthase in Helicobacter pylori-infected patients, BD Biosciences IFN-gamma antibody (BD, B27) was used in flow cytometry on human samples (fig 6c). J Immunol (2016) ncbi
mouse monoclonal (B27)
  • flow cytometry; human; fig 3a
In order to assess the effects of platelet-derived ectosomes on natural killer cells, BD Biosciences IFN-gamma antibody (BD Biosciences, B27) was used in flow cytometry on human samples (fig 3a). J Immunol (2016) ncbi
mouse monoclonal (B27)
  • flow cytometry; human; loading ...; fig s1b
BD Biosciences IFN-gamma antibody (BD, B27) was used in flow cytometry on human samples (fig s1b). J Immunol (2016) ncbi
mouse monoclonal (B27)
  • flow cytometry; human; fig 1d
In order to assess the inflammatory responses in the rectal mucosa of patients with well-defined non-celiac wheat sensitivity, BD Biosciences IFN-gamma antibody (BD Biosciences, B27) was used in flow cytometry on human samples (fig 1d). Clin Transl Gastroenterol (2016) ncbi
mouse monoclonal (B27)
  • flow cytometry; human; loading ...; fig s1
BD Biosciences IFN-gamma antibody (BD Pharmingen, B27) was used in flow cytometry on human samples (fig s1). J Immunol (2016) ncbi
mouse monoclonal (B27)
  • flow cytometry; human; fig 6
In order to study activation of myeloid dendritic cells, regulatory T cells and effector cells in lichen planus, BD Biosciences IFN-gamma antibody (BD Biosciences, B27) was used in flow cytometry on human samples (fig 6). J Transl Med (2016) ncbi
mouse monoclonal (B27)
  • flow cytometry; rhesus macaque; loading ...; fig 4f
In order to optimize vaccination with Aventis Pasteur's canarypox vector-HIV, BD Biosciences IFN-gamma antibody (Beckman Coulter, 554702) was used in flow cytometry on rhesus macaque samples (fig 4f). Nat Med (2016) ncbi
mouse monoclonal (B27)
  • flow cytometry; human; loading ...; fig 3b
BD Biosciences IFN-gamma antibody (BD Biosciences, B27) was used in flow cytometry on human samples (fig 3b). J Immunol (2016) ncbi
mouse monoclonal (B27)
  • flow cytometry; human; loading ...; fig 1a
BD Biosciences IFN-gamma antibody (BD Biosciences, B27) was used in flow cytometry on human samples (fig 1a). J Immunol (2016) ncbi
mouse monoclonal (25723.11)
  • flow cytometry; human; loading ...; fig s5c
In order to investigate NF-KB signaling in natural killer cells, BD Biosciences IFN-gamma antibody (BD Bioscience, 25723.11) was used in flow cytometry on human samples (fig s5c). Nat Commun (2016) ncbi
mouse monoclonal (B27)
  • flow cytometry; African green monkey; loading ...; fig 1c
In order to discuss the use of flow cytometry to examine common marmosets, BD Biosciences IFN-gamma antibody (BD, B27) was used in flow cytometry on African green monkey samples (fig 1c). J Med Primatol (2016) ncbi
mouse monoclonal (B27)
  • flow cytometry; human; loading ...; fig 6b
In order to test if the two hematopoietic systems in patients with mixed chimerism remain functional and study immunological differences, BD Biosciences IFN-gamma antibody (BD Biosciences, B27) was used in flow cytometry on human samples (fig 6b). PLoS ONE (2016) ncbi
mouse monoclonal (B27)
  • flow cytometry; human; fig 3a
BD Biosciences IFN-gamma antibody (BD Bioscience, B27) was used in flow cytometry on human samples (fig 3a). Nat Immunol (2016) ncbi
mouse monoclonal (B27)
  • flow cytometry; human; loading ...; tbl 2
In order to characterize the immune responses of children immunized with Plasmodium falciparum apical membrane antigen 1, BD Biosciences IFN-gamma antibody (BD Biosciences, B27) was used in flow cytometry on human samples (tbl 2). Vaccine (2016) ncbi
mouse monoclonal (B27)
  • flow cytometry; rhesus macaque; loading ...
BD Biosciences IFN-gamma antibody (BD Biosciences, B27) was used in flow cytometry on rhesus macaque samples . PLoS ONE (2016) ncbi
mouse monoclonal (B27)
  • flow cytometry; human; loading ...; fig 4a
In order to examine the expression of CD300 molecules on natural killer cells, BD Biosciences IFN-gamma antibody (BD Biosciences, B27) was used in flow cytometry on human samples (fig 4a). Sci Rep (2016) ncbi
mouse monoclonal (B27)
  • flow cytometry; rhesus macaque; fig 3e
BD Biosciences IFN-gamma antibody (BD Biosciences, B27) was used in flow cytometry on rhesus macaque samples (fig 3e). J Immunol (2016) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; human; fig s1
In order to develop an HLA-A2-specific chimeric antigen receptor and use it to generate alloantigen-specific human T regulatory cells, BD Biosciences IFN-gamma antibody (BD Biosciences, 557844) was used in flow cytometry on human samples (fig s1). J Clin Invest (2016) ncbi
mouse monoclonal (B27)
  • flow cytometry; human
BD Biosciences IFN-gamma antibody (BD, 557995) was used in flow cytometry on human samples . Oncoimmunology (2016) ncbi
mouse monoclonal (25723.11)
  • flow cytometry; human; fig 6
BD Biosciences IFN-gamma antibody (BD Biosciences, 25723.11) was used in flow cytometry on human samples (fig 6). J Virol (2016) ncbi
mouse monoclonal (B27)
  • flow cytometry; African green monkey; loading ...; fig 5a
In order to report that B cells modulate the local granulomatous response in Mycobacterium tuberculosis-infected macaques during acute infection, BD Biosciences IFN-gamma antibody (BD Biosciences, B27) was used in flow cytometry on African green monkey samples (fig 5a). Infect Immun (2016) ncbi
mouse monoclonal (B27)
  • flow cytometry; human; loading ...; fig 4a
In order to examine the contribution of T cells to myasthenia gravis, BD Biosciences IFN-gamma antibody (BD Biosciences, B27) was used in flow cytometry on human samples (fig 4a). J Immunol (2016) ncbi
mouse monoclonal (B27)
  • flow cytometry; human; fig 2d
In order to Targeting CD8(+) T cells prevents psoriasis development, BD Biosciences IFN-gamma antibody (BD Biosciences, B27) was used in flow cytometry on human samples (fig 2d). J Allergy Clin Immunol (2016) ncbi
mouse monoclonal (B27)
  • flow cytometry; human; fig s2
In order to analyze HIV progression traits of a selective loss of early differentiated and highly functional PD1high CD4 T cells, BD Biosciences IFN-gamma antibody (BD Biosciences, B27) was used in flow cytometry on human samples (fig s2). PLoS ONE (2015) ncbi
mouse monoclonal (B27)
  • flow cytometry; human; loading ...; fig 1b
BD Biosciences IFN-gamma antibody (BD, B27) was used in flow cytometry on human samples (fig 1b). J Virol (2016) ncbi
mouse monoclonal (B27)
  • flow cytometry; human; fig 7
BD Biosciences IFN-gamma antibody (BD Biosciences, B27) was used in flow cytometry on human samples (fig 7). Retrovirology (2015) ncbi
mouse monoclonal (B27)
  • flow cytometry; human; loading ...; fig 8b
In order to perform an antigenic analysis of Bla g 2 using antibodies, BD Biosciences IFN-gamma antibody (BD Biosciences, B27) was used in flow cytometry on human samples (fig 8b). J Biol Chem (2016) ncbi
mouse monoclonal (B27)
  • flow cytometry; rhesus macaque; fig 3
In order to assess the ability of HIV-1 envelope glycoprotein-specific broadly neutralizing monoclonal antibodies to suppress acute simian-human immunodeficiency virus replication in rhesus macaques, BD Biosciences IFN-gamma antibody (BD Biosciences, B27) was used in flow cytometry on rhesus macaque samples (fig 3). J Virol (2016) ncbi
mouse monoclonal (B27)
  • flow cytometry; human; fig 2a
In order to develop an antigen presenting cell/T-cell platform to study intrathecal CD4 positive and CD8 positive T-cell responses to candidate MS-associated autoantigens, BD Biosciences IFN-gamma antibody (BD Pharmingen, B27) was used in flow cytometry on human samples (fig 2a). Eur J Immunol (2016) ncbi
mouse monoclonal (B27)
  • flow cytometry; human
BD Biosciences IFN-gamma antibody (BD Biosciences, B27) was used in flow cytometry on human samples . Clin Cancer Res (2016) ncbi
mouse monoclonal (B27)
  • flow cytometry; dogs; fig 5
BD Biosciences IFN-gamma antibody (BD, 559327) was used in flow cytometry on dogs samples (fig 5). Acta Vet Scand (2015) ncbi
mouse monoclonal (B27)
  • flow cytometry; human; loading ...; fig 4c
In order to assess the efficacy of a single vaccination of the Yellow Fever vaccine, BD Biosciences IFN-gamma antibody (BD-PharMingen, 557718) was used in flow cytometry on human samples (fig 4c). Hum Vaccin Immunother (2016) ncbi
mouse monoclonal (B27)
  • flow cytometry; human
In order to study the dynamics of Ag-specific CD4(+) T cells during antiretroviral therapy, BD Biosciences IFN-gamma antibody (BD Biosciences, B27) was used in flow cytometry on human samples . J Immunol (2015) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; human; fig 1
In order to investigate the dynamics and characteristics of natural killer cell types in the human ocular mucosal surface in situ during infection with group D human adenoviruses, BD Biosciences IFN-gamma antibody (BD Biosciences, 4S.B3) was used in flow cytometry on human samples (fig 1). Mucosal Immunol (2016) ncbi
mouse monoclonal (B27)
  • flow cytometry; rhesus macaque; fig 3
In order to elucidate how CD8 positive T cells suppress virus replication during simian immunodeficiency virus infection, BD Biosciences IFN-gamma antibody (BD Pharmingen, B27) was used in flow cytometry on rhesus macaque samples (fig 3). J Virol (2015) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; human; fig 6
BD Biosciences IFN-gamma antibody (BD, 559326) was used in flow cytometry on human samples (fig 6). J Exp Med (2015) ncbi
mouse monoclonal (B27)
  • flow cytometry; human; 1:200; fig 1
BD Biosciences IFN-gamma antibody (BD, 557995) was used in flow cytometry on human samples at 1:200 (fig 1). Nat Commun (2015) ncbi
mouse monoclonal (B27)
  • flow cytometry; human
In order to investigate the primary inflammatory and regulatory T cell responses induced by BCG vaccination in adults, BD Biosciences IFN-gamma antibody (BD Biosciences, clone B27) was used in flow cytometry on human samples . Clin Vaccine Immunol (2015) ncbi
mouse monoclonal (B27)
  • flow cytometry; human
In order to describe an Fc engineering approach that specifically affects antibody-dependent cytokine release, BD Biosciences IFN-gamma antibody (BD PharMingen, 560371) was used in flow cytometry on human samples . MAbs (2015) ncbi
mouse monoclonal (B27)
  • flow cytometry; South American squirrel monkey
  • ELISA; South American squirrel monkey
BD Biosciences IFN-gamma antibody (BD Bioscience, B27) was used in flow cytometry on South American squirrel monkey samples and in ELISA on South American squirrel monkey samples . Malar J (2015) ncbi
mouse monoclonal (B27)
  • flow cytometry; human; loading ...; fig 1b
In order to elucidate Th17 cell polarization, depletion, and restoration in response to HIV infection and antiretroviral therapy, BD Biosciences IFN-gamma antibody (BD Pharmingen, B27) was used in flow cytometry on human samples (fig 1b). Retrovirology (2015) ncbi
mouse monoclonal (B27)
  • flow cytometry; human; 1:20; fig 1
In order to study the immune responses of HIV-infected volunteers vaccinated against tuberculosis, BD Biosciences IFN-gamma antibody (BD, 557995) was used in flow cytometry on human samples at 1:20 (fig 1). Clin Vaccine Immunol (2015) ncbi
mouse monoclonal (B27)
  • flow cytometry; human; fig 3
BD Biosciences IFN-gamma antibody (BD Biosciences, B27) was used in flow cytometry on human samples (fig 3). J Virol (2015) ncbi
mouse monoclonal (B27)
  • flow cytometry; human
BD Biosciences IFN-gamma antibody (BD Biosciences, B27) was used in flow cytometry on human samples . J Immunol (2015) ncbi
mouse monoclonal (B27)
  • flow cytometry; human; 6:100; fig 3b
In order to show that hepatitis B virus exposure in utero enhances immunity to bacterial infections, BD Biosciences IFN-gamma antibody (Becton Dickinson, B27) was used in flow cytometry on human samples at 6:100 (fig 3b). Nat Commun (2015) ncbi
mouse monoclonal (B27)
  • flow cytometry; human; fig 2b
BD Biosciences IFN-gamma antibody (BD Biosciences, B27) was used in flow cytometry on human samples (fig 2b). J Immunol (2015) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; human
In order to measure the memory CD4(+) T-cell responses to each varicella zoster virus protein at baseline and after zoster vaccination, BD Biosciences IFN-gamma antibody (BD, 4S.B3) was used in flow cytometry on human samples . J Infect Dis (2015) ncbi
mouse monoclonal (4S.B3)
  • ELISA; human; fig 1
BD Biosciences IFN-gamma antibody (BD Pharmingen, 554550) was used in ELISA on human samples (fig 1). PLoS ONE (2015) ncbi
mouse monoclonal (B27)
  • flow cytometry; human; fig 5
In order to investigate when Vgamma9Vdelta2 T cells develop, BD Biosciences IFN-gamma antibody (BD Bioscience, B27) was used in flow cytometry on human samples (fig 5). Proc Natl Acad Sci U S A (2015) ncbi
mouse monoclonal (B27)
  • flow cytometry; human
In order to discuss methods to measure cytokine production by Th1 and Th17 cells, BD Biosciences IFN-gamma antibody (BD Horizon, . 562392) was used in flow cytometry on human samples . Curr Protoc Cytom (2015) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; human; loading ...; fig 1a
In order to determine the role of IL-10 produced by T regulatory cells in patients with immune thrombocytopenia, BD Biosciences IFN-gamma antibody (BD Bioscience, 557074) was used in flow cytometry on human samples (fig 1a). Immunol Res (2015) ncbi
mouse monoclonal (B27)
  • flow cytometry; human
BD Biosciences IFN-gamma antibody (BD Biosciences, B27) was used in flow cytometry on human samples . J Immunol (2015) ncbi
mouse monoclonal (25723.11)
  • flow cytometry; human
In order to assess the effects of long-term cryopreservation of fixed cells on the measurement of mycobacteria induced CD4 T cell immunity, BD Biosciences IFN-gamma antibody (BD Biosciences, 25723.11) was used in flow cytometry on human samples . J Immunol Methods (2015) ncbi
mouse monoclonal (B27)
  • flow cytometry; human
In order to assess the effects of long-term cryopreservation of fixed cells on the measurement of mycobacteria induced CD4 T cell immunity, BD Biosciences IFN-gamma antibody (BD Biosciences, B27) was used in flow cytometry on human samples . J Immunol Methods (2015) ncbi
mouse monoclonal (25723.11)
  • flow cytometry; human
BD Biosciences IFN-gamma antibody (BD Bioscience, 25723.11) was used in flow cytometry on human samples . Immun Inflamm Dis (2014) ncbi
mouse monoclonal (B27)
  • flow cytometry; human
In order to discuss how inflammation contributes to pulmonary arterial hypertension, BD Biosciences IFN-gamma antibody (BD Pharmingen, B27) was used in flow cytometry on human samples . Chest (2015) ncbi
mouse monoclonal (B27)
  • flow cytometry; human
BD Biosciences IFN-gamma antibody (BD, B27) was used in flow cytometry on human samples . J Immunol (2015) ncbi
mouse monoclonal (B27)
  • flow cytometry; human
In order to examine the role of TLR7 in HIV-infected CD4 positive T cells, BD Biosciences IFN-gamma antibody (BD, B27) was used in flow cytometry on human samples . Nat Immunol (2015) ncbi
mouse monoclonal (25723.11)
  • flow cytometry; human; 1:10
BD Biosciences IFN-gamma antibody (BD Biosciences, 25723.11) was used in flow cytometry on human samples at 1:10. Nat Commun (2014) ncbi
mouse monoclonal (B27)
  • flow cytometry; human; fig 7
BD Biosciences IFN-gamma antibody (BD Biosciences, B27) was used in flow cytometry on human samples (fig 7). Immunol Cell Biol (2015) ncbi
mouse monoclonal (B27)
  • flow cytometry; rhesus macaque
BD Biosciences IFN-gamma antibody (BD Biosciences, B27) was used in flow cytometry on rhesus macaque samples . J Immunol (2014) ncbi
mouse monoclonal (B27)
  • flow cytometry; human
BD Biosciences IFN-gamma antibody (BD Biosciences, B27) was used in flow cytometry on human samples . J Gen Virol (2015) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; human
BD Biosciences IFN-gamma antibody (BD Biosciences, 4S.B3) was used in flow cytometry on human samples . Rheumatology (Oxford) (2015) ncbi
mouse monoclonal (B27)
  • flow cytometry; human
BD Biosciences IFN-gamma antibody (BD Pharmingen, B27) was used in flow cytometry on human samples . PLoS ONE (2014) ncbi
mouse monoclonal (B27)
  • immunocytochemistry; human
In order to study the role of dendritic cells in relation to T cells, BD Biosciences IFN-gamma antibody (BD Biosciences, B27) was used in immunocytochemistry on human samples . J Immunol (2014) ncbi
mouse monoclonal (B27)
  • flow cytometry; rhesus macaque
BD Biosciences IFN-gamma antibody (BD Biosciences, B27) was used in flow cytometry on rhesus macaque samples . J Immunol (2014) ncbi
mouse monoclonal (B27)
  • flow cytometry; human
BD Biosciences IFN-gamma antibody (BD, B27) was used in flow cytometry on human samples . Eur J Immunol (2014) ncbi
mouse monoclonal (B27)
  • flow cytometry; human; fig 2
In order to compare five SIV vaccine platforms, BD Biosciences IFN-gamma antibody (BD Pharmingen, clone B27) was used in flow cytometry on human samples (fig 2). Clin Immunol (2014) ncbi
mouse monoclonal (B27)
  • flow cytometry; human
In order to test the safety and immunogenicity of an adenovirus 35-vectored tuberculosis vaccine candidate AERAS-402 in infants, BD Biosciences IFN-gamma antibody (BD Biosciences, Clone B27) was used in flow cytometry on human samples . Vaccine (2014) ncbi
mouse monoclonal (B27)
  • flow cytometry; human
In order to identify the role of GammaDelta T cells in acute HIV infection, BD Biosciences IFN-gamma antibody (BD Pharmingen, B27) was used in flow cytometry on human samples . PLoS ONE (2014) ncbi
mouse monoclonal (B27)
  • flow cytometry; human
BD Biosciences IFN-gamma antibody (BD Biosciences, B27) was used in flow cytometry on human samples . J Immunol (2014) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; rhesus macaque
In order to examine the effect of HMBPP-deficient Listeria mutant immunization, BD Biosciences IFN-gamma antibody (BD Biosciences, 4S.B3) was used in flow cytometry on rhesus macaque samples . J Leukoc Biol (2014) ncbi
mouse monoclonal (B27)
  • flow cytometry; rhesus macaque
BD Biosciences IFN-gamma antibody (BD Biosciences, B27) was used in flow cytometry on rhesus macaque samples . Blood (2014) ncbi
mouse monoclonal (B27)
  • flow cytometry; human
BD Biosciences IFN-gamma antibody (BD Bioscience, B27) was used in flow cytometry on human samples . PLoS Pathog (2014) ncbi
mouse monoclonal (25723.11)
  • flow cytometry; human
BD Biosciences IFN-gamma antibody (BD Biosciences, 25723.11) was used in flow cytometry on human samples . PLoS ONE (2014) ncbi
mouse monoclonal (B27)
  • flow cytometry; rhesus macaque; loading ...; fig 5b
In order to explore germinal center-related hyperimmune responses and disease severity during viral infection, BD Biosciences IFN-gamma antibody (BD, B27) was used in flow cytometry on rhesus macaque samples (fig 5b). J Immunol (2014) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; human
BD Biosciences IFN-gamma antibody (BD Pharmingen, 4S.B3) was used in flow cytometry on human samples . Virol J (2014) ncbi
mouse monoclonal (B27)
  • flow cytometry; human
BD Biosciences IFN-gamma antibody (BD, B27) was used in flow cytometry on human samples . J Exp Med (2014) ncbi
mouse monoclonal (4S.B3)
  • flow cytometry; human; loading ...; fig 6c
BD Biosciences IFN-gamma antibody (BD Bioscience, 4S.B3) was used in flow cytometry on human samples (fig 6c). J Immunol (2014) ncbi
mouse monoclonal (B27)
  • flow cytometry; human
BD Biosciences IFN-gamma antibody (BD Biosciences, B27) was used in flow cytometry on human samples . J Immunol (2014) ncbi
mouse monoclonal (B27)
  • ELISA; human; fig 3
In order to report enhanced anticancer immunity using dendritic cells to present endocytosed material and initiate T cell immunity, BD Biosciences IFN-gamma antibody (BD Biosciences, B27) was used in ELISA on human samples (fig 3). Sci Transl Med (2014) ncbi
mouse monoclonal (B27)
  • flow cytometry; rhesus macaque
In order to compare vaccination with highly conserved gag elements verses full-length gag DNA, BD Biosciences IFN-gamma antibody (BD, B27) was used in flow cytometry on rhesus macaque samples . PLoS ONE (2014) ncbi
mouse monoclonal (B27)
  • flow cytometry; human; fig 1
In order to study mucosal associated invariant T cells and B cell interactions, BD Biosciences IFN-gamma antibody (BD Pharmingen, clone B27) was used in flow cytometry on human samples (fig 1). Front Immunol (2014) ncbi
mouse monoclonal (B27)
  • flow cytometry; human; loading ...; fig 1a
In order to assess the effect of delayed administration of the BCG vaccine on the induced immune response in Ugandan children, BD Biosciences IFN-gamma antibody (BD Biosciences, B27) was used in flow cytometry on human samples (fig 1a). J Infect Dis (2014) ncbi
Articles Reviewed
  1. Gregorova M, Morse D, Brignoli T, Steventon J, Hamilton F, Albur M, et al. Post-acute COVID-19 associated with evidence of bystander T-cell activation and a recurring antibiotic-resistant bacterial pneumonia. elife. 2020;9: pubmed publisher
  2. Moreno Valladares M, Moreno Cugnon L, Silva T, Garcés J, Sáenz Antoñanzas A, Álvarez Satta M, et al. CD8+ T cells are increased in the subventricular zone with physiological and pathological aging. Aging Cell. 2020;:e13198 pubmed publisher
  3. Mathew D, Giles J, Baxter A, Greenplate A, Wu J, Alanio C, et al. Deep immune profiling of COVID-19 patients reveals patient heterogeneity and distinct immunotypes with implications for therapeutic interventions. bioRxiv. 2020;: pubmed publisher
  4. Gunesch J, Dixon A, Ebrahim T, Berrien Elliott M, Tatineni S, Kumar T, et al. CD56 regulates human NK cell cytotoxicity through Pyk2. elife. 2020;9: pubmed publisher
  5. Oh D, Kwek S, Raju S, Li T, McCarthy E, Chow E, et al. Intratumoral CD4+ T Cells Mediate Anti-tumor Cytotoxicity in Human Bladder Cancer. Cell. 2020;181:1612-1625.e13 pubmed publisher
  6. Grifoni A, Weiskopf D, Ramirez S, Mateus J, Dan J, Moderbacher C, et al. Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals. Cell. 2020;181:1489-1501.e15 pubmed publisher
  7. Cao W, Fang F, Gould T, Li X, Kim C, Gustafson C, et al. Ecto-NTPDase CD39 is a negative checkpoint that inhibits follicular helper cell generation. J Clin Invest. 2020;130:3422-3436 pubmed publisher
  8. Hanaoka H, Nishimoto T, Okazaki Y, Takeuchi T, Kuwana M. A unique thymus-derived regulatory T cell subset associated with systemic lupus erythematosus. Arthritis Res Ther. 2020;22:88 pubmed publisher
  9. Ryu S, Lee E, Kim D, Kim Y, Chung D, Kim J, et al. Reduction of circulating innate lymphoid cell progenitors results in impaired cytokine production by innate lymphoid cells in patients with lupus nephritis. Arthritis Res Ther. 2020;22:63 pubmed publisher
  10. Martin E, Minet N, Boschat A, Sanquer S, Sobrino S, Lenoir C, et al. Impaired lymphocyte function and differentiation in CTPS1-deficient patients result from a hypomorphic homozygous mutation. JCI Insight. 2020;5: pubmed publisher
  11. Okumura G, Iguchi Manaka A, Murata R, Yamashita Kanemaru Y, Shibuya A, Shibuya K. Tumor-derived soluble CD155 inhibits DNAM-1-mediated antitumor activity of natural killer cells. J Exp Med. 2020;217: pubmed publisher
  12. Marotte L, Simon S, Vignard V, Dupré E, Gantier M, Cruard J, et al. Increased antitumor efficacy of PD-1-deficient melanoma-specific human lymphocytes. J Immunother Cancer. 2020;8: pubmed publisher
  13. Lee J, Hall J, Kroehling L, Wu L, Najar T, Nguyen H, et al. Serum Amyloid A Proteins Induce Pathogenic Th17 Cells and Promote Inflammatory Disease. Cell. 2020;180:79-91.e16 pubmed publisher
  14. Lynn R, Weber E, Sotillo E, Gennert D, Xu P, Good Z, et al. c-Jun overexpression in CAR T cells induces exhaustion resistance. Nature. 2019;576:293-300 pubmed publisher
  15. Martínez Fábregas J, Wilmes S, Wang L, Hafer M, Pohler E, Lokau J, et al. Kinetics of cytokine receptor trafficking determine signaling and functional selectivity. elife. 2019;8: pubmed publisher
  16. Ma A, Motyka B, Gutfreund K, Shi Y, George R. A dendritic cell receptor-targeted chimeric immunotherapeutic protein (C-HBV) for the treatment of chronic hepatitis B. Hum Vaccin Immunother. 2020;16:756-778 pubmed publisher
  17. Sanz Ortega L, Rojas J, Portilla Y, Pérez Yagüe S, Barber D. Magnetic Nanoparticles Attached to the NK Cell Surface for Tumor Targeting in Adoptive Transfer Therapies Does Not Affect Cellular Effector Functions. Front Immunol. 2019;10:2073 pubmed publisher
  18. Di Blasi D, Boldanova T, Mori L, Terracciano L, Heim M, De Libero G. Unique T-Cell Populations Define Immune-Inflamed Hepatocellular Carcinoma. Cell Mol Gastroenterol Hepatol. 2020;9:195-218 pubmed publisher
  19. Crank M, Ruckwardt T, Chen M, Morabito K, Phung E, Costner P, et al. A proof of concept for structure-based vaccine design targeting RSV in humans. Science. 2019;365:505-509 pubmed publisher
  20. Meckiff B, Ladell K, McLaren J, Ryan G, Leese A, James E, et al. Primary EBV Infection Induces an Acute Wave of Activated Antigen-Specific Cytotoxic CD4+ T Cells. J Immunol. 2019;203:1276-1287 pubmed publisher
  21. Jennewein M, Goldfarb I, Dolatshahi S, Cosgrove C, Noelette F, Krykbaeva M, et al. Fc Glycan-Mediated Regulation of Placental Antibody Transfer. Cell. 2019;: pubmed publisher
  22. Gauthier L, Morel A, Anceriz N, Rossi B, Blanchard Alvarez A, Grondin G, et al. Multifunctional Natural Killer Cell Engagers Targeting NKp46 Trigger Protective Tumor Immunity. Cell. 2019;177:1701-1713.e16 pubmed publisher
  23. Ahmed R, Omidian Z, Giwa A, Cornwell B, Majety N, Bell D, et al. A Public BCR Present in a Unique Dual-Receptor-Expressing Lymphocyte from Type 1 Diabetes Patients Encodes a Potent T Cell Autoantigen. Cell. 2019;177:1583-1599.e16 pubmed publisher
  24. Yuan Y, Zhao Q, Zhao S, Zhang P, Zhao H, Li Z, et al. Characterization of transcriptome profile and clinical features of a novel immunotherapy target CD204 in diffuse glioma. Cancer Med. 2019;8:3811-3821 pubmed publisher
  25. Fernandez I, Baxter R, Garcia Perez J, Vendrame E, Ranganath T, Kong D, et al. A novel human IL2RB mutation results in T and NK cell-driven immune dysregulation. J Exp Med. 2019;216:1255-1267 pubmed publisher
  26. Thauland T, Pellerin L, Ohgami R, Bacchetta R, Butte M. Case Study: Mechanism for Increased Follicular Helper T Cell Development in Activated PI3K Delta Syndrome. Front Immunol. 2019;10:753 pubmed publisher
  27. Wu J, Ma S, Sandhoff R, Ming Y, Hotz Wagenblatt A, Timmerman V, et al. Loss of Neurological Disease HSAN-I-Associated Gene SPTLC2 Impairs CD8+ T Cell Responses to Infection by Inhibiting T Cell Metabolic Fitness. Immunity. 2019;50:1218-1231.e5 pubmed publisher
  28. van de Garde M, van Westen E, Poelen M, Rots N, van Els C. Prediction and Validation of Immunogenic Domains of Pneumococcal Proteins Recognized by Human CD4+ T Cells. Infect Immun. 2019;87: pubmed publisher
  29. Bacher P, Hohnstein T, Beerbaum E, Röcker M, Blango M, Kaufmann S, et al. Human Anti-fungal Th17 Immunity and Pathology Rely on Cross-Reactivity against Candida albicans. Cell. 2019;: pubmed publisher
  30. Lodygin D, Hermann M, Schweingruber N, Flügel Koch C, Watanabe T, Schlosser C, et al. β-Synuclein-reactive T cells induce autoimmune CNS grey matter degeneration. Nature. 2019;566:503-508 pubmed publisher
  31. Lichnog C, Klabunde S, Becker E, Fuh F, Tripal P, Atreya R, et al. Cellular Mechanisms of Etrolizumab Treatment in Inflammatory Bowel Disease. Front Pharmacol. 2019;10:39 pubmed publisher
  32. Karimzadeh H, Kiraithe M, Oberhardt V, Salimi Alizei E, Bockmann J, Schulze zur Wiesch J, et al. Mutations in Hepatitis D Virus Allow It to Escape Detection by CD8+ T Cells and Evolve at the Population Level. Gastroenterology. 2019;156:1820-1833 pubmed publisher
  33. Mayassi T, Ladell K, Gudjonson H, McLaren J, Shaw D, Tran M, et al. Chronic Inflammation Permanently Reshapes Tissue-Resident Immunity in Celiac Disease. Cell. 2019;176:967-981.e19 pubmed publisher
  34. Wen Z, Jin K, Shen Y, Yang Z, Li Y, Wu B, et al. N-myristoyltransferase deficiency impairs activation of kinase AMPK and promotes synovial tissue inflammation. Nat Immunol. 2019;20:313-325 pubmed publisher
  35. Banki Z, Krabbendam L, Klaver D, Leng T, Kruis S, Mehta H, et al. Antibody opsonization enhances MAIT cell responsiveness to bacteria via a TNF-dependent mechanism. Immunol Cell Biol. 2019;97:538-551 pubmed publisher
  36. Hallner A, Bernson E, Hussein B, Sander F, Brune M, Aurelius J, et al. The HLA-B -21 dimorphism impacts on NK cell education and clinical outcome of immunotherapy in acute myeloid leukemia. Blood. 2019;: pubmed publisher
  37. Kumar A, Lee J, Suknuntha K, D Souza S, Thakur A, Slukvin I. NOTCH Activation at the Hematovascular Mesoderm Stage Facilitates Efficient Generation of T Cells with High Proliferation Potential from Human Pluripotent Stem Cells. J Immunol. 2019;202:770-776 pubmed publisher
  38. Amelio P, Portevin D, Hella J, Reither K, Kamwela L, Lweno O, et al. HIV Infection Functionally Impairs Mycobacterium tuberculosis-Specific CD4 and CD8 T-Cell Responses. J Virol. 2019;93: pubmed publisher
  39. Jegaskanda S, Vanderven H, Tan H, Alcantara S, Wragg K, Parsons M, et al. Influenza Virus Infection Enhances Antibody-Mediated NK Cell Functions via Type I Interferon-Dependent Pathways. J Virol. 2019;93: pubmed publisher
  40. Scheper W, Kelderman S, Fanchi L, Linnemann C, Bendle G, de Rooij M, et al. Low and variable tumor reactivity of the intratumoral TCR repertoire in human cancers. Nat Med. 2019;25:89-94 pubmed publisher
  41. Andre P, Denis C, Soulas C, Bourbon Caillet C, Lopez J, Arnoux T, et al. Anti-NKG2A mAb Is a Checkpoint Inhibitor that Promotes Anti-tumor Immunity by Unleashing Both T and NK Cells. Cell. 2018;175:1731-1743.e13 pubmed publisher
  42. Kim C, Hu B, Jadhav R, Jin J, Zhang H, Cavanagh M, et al. Activation of miR-21-Regulated Pathways in Immune Aging Selects against Signatures Characteristic of Memory T Cells. Cell Rep. 2018;25:2148-2162.e5 pubmed publisher
  43. Aulicino A, Rue Albrecht K, Preciado Llanes L, Napolitani G, Ashley N, Cribbs A, et al. Invasive Salmonella exploits divergent immune evasion strategies in infected and bystander dendritic cell subsets. Nat Commun. 2018;9:4883 pubmed publisher
  44. Dias J, Boulouis C, Gorin J, van den Biggelaar R, Lal K, Gibbs A, et al. The CD4-CD8- MAIT cell subpopulation is a functionally distinct subset developmentally related to the main CD8+ MAIT cell pool. Proc Natl Acad Sci U S A. 2018;115:E11513-E11522 pubmed publisher
  45. Wagner D, Amini L, Wendering D, Burkhardt L, Akyüz L, Reinke P, et al. High prevalence of Streptococcus pyogenes Cas9-reactive T cells within the adult human population. Nat Med. 2019;25:242-248 pubmed publisher
  46. Song M, Sandoval T, Chae C, Chopra S, Tan C, Rutkowski M, et al. IRE1α-XBP1 controls T cell function in ovarian cancer by regulating mitochondrial activity. Nature. 2018;562:423-428 pubmed publisher
  47. Ye W, Chew M, Hou J, Lai F, Leopold S, Loo H, et al. Microvesicles from malaria-infected red blood cells activate natural killer cells via MDA5 pathway. PLoS Pathog. 2018;14:e1007298 pubmed publisher
  48. Bradley T, Peppa D, Pedroza Pacheco I, Li D, Cain D, Henao R, et al. RAB11FIP5 Expression and Altered Natural Killer Cell Function Are Associated with Induction of HIV Broadly Neutralizing Antibody Responses. Cell. 2018;175:387-399.e17 pubmed publisher
  49. van Erp E, Feyaerts D, Duijst M, Mulder H, Wicht O, Luytjes W, et al. Respiratory Syncytial Virus Infects Primary Neonatal and Adult Natural Killer Cells and Affects Their Antiviral Effector Function. J Infect Dis. 2019;219:723-733 pubmed publisher
  50. Patel N, Vukmanovic Stejic M, Suárez Fariñas M, Chambers E, Sandhu D, Fuentes Duculan J, et al. Impact of Zostavax Vaccination on T-Cell Accumulation and Cutaneous Gene Expression in the Skin of Older Humans After Varicella Zoster Virus Antigen-Specific Challenge. J Infect Dis. 2018;218:S88-S98 pubmed publisher
  51. Petrelli A, Mijnheer G, Hoytema van Konijnenburg D, van der Wal M, Giovannone B, Mocholí E, et al. PD-1+CD8+ T cells are clonally expanding effectors in human chronic inflammation. J Clin Invest. 2018;128:4669-4681 pubmed publisher
  52. Watanabe N, Takaku T, Takeda K, Shirane S, Toyota T, Koike M, et al. Dasatinib-induced anti-leukemia cellular immunity through a novel subset of CD57 positive helper/cytotoxic CD4 T cells in chronic myelogenous leukemia patients. Int J Hematol. 2018;108:588-597 pubmed publisher
  53. Walwyn Brown K, Guldevall K, Saeed M, Pende D, Önfelt B, MacDonald A, et al. Human NK Cells Lyse Th2-Polarizing Dendritic Cells via NKp30 and DNAM-1. J Immunol. 2018;201:2028-2041 pubmed publisher
  54. Levin M, Kroehl M, Johnson M, Hammes A, Reinhold D, Lang N, et al. Th1 memory differentiates recombinant from live herpes zoster vaccines. J Clin Invest. 2018;128:4429-4440 pubmed publisher
  55. Yang T, St John L, Garber H, Kerros C, Ruisaard K, Clise Dwyer K, et al. Membrane-Associated Proteinase 3 on Granulocytes and Acute Myeloid Leukemia Inhibits T Cell Proliferation. J Immunol. 2018;201:1389-1399 pubmed publisher
  56. D Addio F, Vergani A, Potena L, Maestroni A, Usuelli V, Ben Nasr M, et al. P2X7R mutation disrupts the NLRP3-mediated Th program and predicts poor cardiac allograft outcomes. J Clin Invest. 2018;128:3490-3503 pubmed publisher
  57. Srpan K, Ambrose A, Karampatzakis A, Saeed M, Cartwright A, Guldevall K, et al. Shedding of CD16 disassembles the NK cell immune synapse and boosts serial engagement of target cells. J Cell Biol. 2018;217:3267-3283 pubmed publisher
  58. Jung I, Kim Y, Yu H, Lee M, Kim S, Lee J. CRISPR/Cas9-Mediated Knockout of DGK Improves Antitumor Activities of Human T Cells. Cancer Res. 2018;78:4692-4703 pubmed publisher
  59. Boutboul D, Kuehn H, Van de Wyngaert Z, Niemela J, Callebaut I, Stoddard J, et al. Dominant-negative IKZF1 mutations cause a T, B, and myeloid cell combined immunodeficiency. J Clin Invest. 2018;128:3071-3087 pubmed publisher
  60. Capuano C, Battella S, Pighi C, Franchitti L, Turriziani O, Morrone S, et al. Tumor-Targeting Anti-CD20 Antibodies Mediate In Vitro Expansion of Memory Natural Killer Cells: Impact of CD16 Affinity Ligation Conditions and In Vivo Priming. Front Immunol. 2018;9:1031 pubmed publisher
  61. Zacharakis N, Chinnasamy H, Black M, Xu H, Lu Y, Zheng Z, et al. Immune recognition of somatic mutations leading to complete durable regression in metastatic breast cancer. Nat Med. 2018;24:724-730 pubmed publisher
  62. García Nores G, Ly C, Cuzzone D, Kataru R, Hespe G, Torrisi J, et al. CD4+ T cells are activated in regional lymph nodes and migrate to skin to initiate lymphedema. Nat Commun. 2018;9:1970 pubmed publisher
  63. Provine N, Binder B, FitzPatrick M, Schuch A, Garner L, Williamson K, et al. Unique and Common Features of Innate-Like Human Vδ2+ γδT Cells and Mucosal-Associated Invariant T Cells. Front Immunol. 2018;9:756 pubmed publisher
  64. Clayton K, Collins D, Lengieza J, Ghebremichael M, Dotiwala F, Lieberman J, et al. Resistance of HIV-infected macrophages to CD8+ T lymphocyte-mediated killing drives activation of the immune system. Nat Immunol. 2018;19:475-486 pubmed publisher
  65. Shi Y, Zhang P, Wang G, Liu X, Sun X, Zhang X, et al. Description of organ-specific phenotype, and functional characteristics of tissue resident lymphocytes from liver transplantation donor and research on immune tolerance mechanism of liver. Oncotarget. 2018;9:15552-15565 pubmed publisher
  66. Zhang C, Peng Y, Hublitz P, Zhang H, Dong T. Genetic abrogation of immune checkpoints in antigen-specific cytotoxic T-lymphocyte as a potential alternative to blockade immunotherapy. Sci Rep. 2018;8:5549 pubmed publisher
  67. Li M, Zhang W, Liu J, Li M, Zhang Y, Xiong Y, et al. Dynamic changes in the immunological characteristics of T lymphocytes in surviving patients with severe fever with thrombocytopenia syndrome (SFTS). Int J Infect Dis. 2018;70:72-80 pubmed publisher
  68. Stanko K, Iwert C, Appelt C, Vogt K, Schumann J, Strunk F, et al. CD96 expression determines the inflammatory potential of IL-9-producing Th9 cells. Proc Natl Acad Sci U S A. 2018;115:E2940-E2949 pubmed publisher
  69. Li N, van Unen V, Höllt T, Thompson A, van Bergen J, Pezzotti N, et al. Mass cytometry reveals innate lymphoid cell differentiation pathways in the human fetal intestine. J Exp Med. 2018;215:1383-1396 pubmed publisher
  70. Oei V, Siernicka M, Graczyk Jarzynka A, Hoel H, Yang W, Palacios D, et al. Intrinsic Functional Potential of NK-Cell Subsets Constrains Retargeting Driven by Chimeric Antigen Receptors. Cancer Immunol Res. 2018;6:467-480 pubmed publisher
  71. Seki A, Rutz S. Optimized RNP transfection for highly efficient CRISPR/Cas9-mediated gene knockout in primary T cells. J Exp Med. 2018;215:985-997 pubmed publisher
  72. Hsieh W, Hsu T, Chang Y, Lai M. IL-6 receptor blockade corrects defects of XIAP-deficient regulatory T cells. Nat Commun. 2018;9:463 pubmed publisher
  73. Linehan J, Harrison O, Han S, Byrd A, Vujkovic Cvijin I, Villarino A, et al. Non-classical Immunity Controls Microbiota Impact on Skin Immunity and Tissue Repair. Cell. 2018;172:784-796.e18 pubmed publisher
  74. Pizzolla A, Nguyen T, Sant S, Jaffar J, Loudovaris T, Mannering S, et al. Influenza-specific lung-resident memory T cells are proliferative and polyfunctional and maintain diverse TCR profiles. J Clin Invest. 2018;128:721-733 pubmed publisher
  75. Barrow A, Edeling M, Trifonov V, Luo J, Goyal P, Bohl B, et al. Natural Killer Cells Control Tumor Growth by Sensing a Growth Factor. Cell. 2018;172:534-548.e19 pubmed publisher
  76. Gee M, Han A, Lofgren S, Beausang J, Mendoza J, Birnbaum M, et al. Antigen Identification for Orphan T Cell Receptors Expressed on Tumor-Infiltrating Lymphocytes. Cell. 2018;172:549-563.e16 pubmed publisher
  77. Pugh J, Nemat Gorgani N, Norman P, Guethlein L, Parham P. Human NK Cells Downregulate Zap70 and Syk in Response to Prolonged Activation or DNA Damage. J Immunol. 2018;200:1146-1158 pubmed publisher
  78. Jeffery H, McDowell P, Lutz P, Wawman R, Roberts S, Bagnall C, et al. Human intrahepatic ILC2 are IL-13positive amphiregulinpositive and their frequency correlates with model of end stage liver disease score. PLoS ONE. 2017;12:e0188649 pubmed publisher
  79. Wang C, Edilova M, Wagar L, Mujib S, Singer M, Bernard N, et al. Effect of IL-7 Therapy on Phospho-Ribosomal Protein S6 and TRAF1 Expression in HIV-Specific CD8 T Cells in Patients Receiving Antiretroviral Therapy. J Immunol. 2018;200:558-564 pubmed publisher
  80. Johnson R, Yu H, Strank N, Karunakaran K, Zhu Y, Brunham R. B Cell Presentation of Chlamydia Antigen Selects Out Protective CD4?13 T Cells: Implications for Genital Tract Tissue-Resident Memory Lymphocyte Clusters. Infect Immun. 2018;86: pubmed publisher
  81. Herndler Brandstetter D, Shan L, Yao Y, Stecher C, Plajer V, Lietzenmayer M, et al. Humanized mouse model supports development, function, and tissue residency of human natural killer cells. Proc Natl Acad Sci U S A. 2017;114:E9626-E9634 pubmed publisher
  82. Meng Y, Zhou W, Jin L, Liu L, Chang K, Mei J, et al. RANKL-mediated harmonious dialogue between fetus and mother guarantees smooth gestation by inducing decidual M2 macrophage polarization. Cell Death Dis. 2017;8:e3105 pubmed publisher
  83. Hydes T, Noll A, Salinas Riester G, Abuhilal M, Armstrong T, Hamady Z, et al. IL-12 and IL-15 induce the expression of CXCR6 and CD49a on peripheral natural killer cells. Immun Inflamm Dis. 2018;6:34-46 pubmed publisher
  84. Molnar C, Scherer A, Baraliakos X, de Hooge M, Micheroli R, Exer P, et al. TNF blockers inhibit spinal radiographic progression in ankylosing spondylitis by reducing disease activity: results from the Swiss Clinical Quality Management cohort. Ann Rheum Dis. 2018;77:63-69 pubmed publisher
  85. Jackson E, Zhang C, Kiani Z, Lisovsky I, Tallon B, Del Corpo A, et al. HIV exposed seronegative (HESN) compared to HIV infected individuals have higher frequencies of telomeric Killer Immunoglobulin-like Receptor (KIR) B motifs; Contribution of KIR B motif encoded genes to NK cell responsiveness. PLoS ONE. 2017;12:e0185160 pubmed publisher
  86. Salio M, Gasser O, González López C, Martens A, Veerapen N, Gileadi U, et al. Activation of Human Mucosal-Associated Invariant T Cells Induces CD40L-Dependent Maturation of Monocyte-Derived and Primary Dendritic Cells. J Immunol. 2017;199:2631-2638 pubmed publisher
  87. Zhang X, Lian X, Dai Z, Zheng H, Chen X, Zheng Y. ?3-Deletion Isoform of HLA-A11 Modulates Cytotoxicity of NK Cells: Correlations with HIV-1 Infection of Cells. J Immunol. 2017;199:2030-2042 pubmed publisher
  88. Ott P, Hu Z, Keskin D, Shukla S, Sun J, Bozym D, et al. An immunogenic personal neoantigen vaccine for patients with melanoma. Nature. 2017;547:217-221 pubmed publisher
  89. Chew V, Lai L, Pan L, Lim C, Li J, Ong R, et al. Delineation of an immunosuppressive gradient in hepatocellular carcinoma using high-dimensional proteomic and transcriptomic analyses. Proc Natl Acad Sci U S A. 2017;114:E5900-E5909 pubmed publisher
  90. Dias J, Leeansyah E, Sandberg J. Multiple layers of heterogeneity and subset diversity in human MAIT cell responses to distinct microorganisms and to innate cytokines. Proc Natl Acad Sci U S A. 2017;114:E5434-E5443 pubmed publisher
  91. Watanabe R, Shirai T, Namkoong H, Zhang H, Berry G, Wallis B, et al. Pyruvate controls the checkpoint inhibitor PD-L1 and suppresses T cell immunity. J Clin Invest. 2017;127:2725-2738 pubmed publisher
  92. Lu G, Zhang X, Shen L, Qiao Q, Li Y, Sun J, et al. CCL20 secreted from IgA1-stimulated human mesangial cells recruits inflammatory Th17 cells in IgA nephropathy. PLoS ONE. 2017;12:e0178352 pubmed publisher
  93. Iampietro M, Younan P, Nishida A, Dutta M, Lubaki N, Santos R, et al. Ebola virus glycoprotein directly triggers T lymphocyte death despite of the lack of infection. PLoS Pathog. 2017;13:e1006397 pubmed publisher
  94. Domae E, Hirai Y, Ikeo T, Goda S, Shimizu Y. Cytokine-mediated activation of human ex vivo-expanded V?9V?2 T cells. Oncotarget. 2017;8:45928-45942 pubmed publisher
  95. Tong A, Hashem H, Eid S, Allen F, Kingsley D, Huang A. Adoptive natural killer cell therapy is effective in reducing pulmonary metastasis of Ewing sarcoma. Oncoimmunology. 2017;6:e1303586 pubmed publisher
  96. Djaoud Z, Guethlein L, Horowitz A, Azzi T, Nemat Gorgani N, Olive D, et al. Two alternate strategies for innate immunity to Epstein-Barr virus: One using NK cells and the other NK cells and ?? T cells. J Exp Med. 2017;214:1827-1841 pubmed publisher
  97. Chen C, Sun W, Chen J, Huang J. Dynamic variations of the peripheral blood immune cell subpopulation in patients with critical H7N9 swine-origin influenza A virus infection: A retrospective small-scale study. Exp Ther Med. 2017;13:1490-1494 pubmed publisher
  98. Stevanović S, Pasetto A, Helman S, Gartner J, Prickett T, Howie B, et al. Landscape of immunogenic tumor antigens in successful immunotherapy of virally induced epithelial cancer. Science. 2017;356:200-205 pubmed publisher
  99. Van Caeneghem Y, De Munter S, Tieppo P, Goetgeluk G, Weening K, Verstichel G, et al. Antigen receptor-redirected T cells derived from hematopoietic precursor cells lack expression of the endogenous TCR/CD3 receptor and exhibit specific antitumor capacities. Oncoimmunology. 2017;6:e1283460 pubmed publisher
  100. Nelde A, Walz J, Kowalewski D, Schuster H, Wolz O, Peper J, et al. HLA class I-restricted MYD88 L265P-derived peptides as specific targets for lymphoma immunotherapy. Oncoimmunology. 2017;6:e1219825 pubmed publisher
  101. Gaggianesi M, Turdo A, Chinnici A, Lipari E, Apuzzo T, Benfante A, et al. IL4 Primes the Dynamics of Breast Cancer Progression via DUSP4 Inhibition. Cancer Res. 2017;77:3268-3279 pubmed publisher
  102. Dowling D, van Haren S, Scheid A, Bergelson I, Kim D, Mancuso C, et al. TLR7/8 adjuvant overcomes newborn hyporesponsiveness to pneumococcal conjugate vaccine at birth. JCI Insight. 2017;2:e91020 pubmed publisher
  103. Tyler C, McCarthy N, Lindsay J, Stagg A, Moser B, Eberl M. Antigen-Presenting Human γδ T Cells Promote Intestinal CD4+ T Cell Expression of IL-22 and Mucosal Release of Calprotectin. J Immunol. 2017;198:3417-3425 pubmed publisher
  104. Whitfield S, Taylor C, Risdall J, Griffiths G, Jones J, Williamson E, et al. Interference of the T Cell and Antigen-Presenting Cell Costimulatory Pathway Using CTLA4-Ig (Abatacept) Prevents Staphylococcal Enterotoxin B Pathology. J Immunol. 2017;198:3989-3998 pubmed publisher
  105. Klinker M, Marklein R, Lo Surdo J, Wei C, Bauer S. Morphological features of IFN-γ-stimulated mesenchymal stromal cells predict overall immunosuppressive capacity. Proc Natl Acad Sci U S A. 2017;114:E2598-E2607 pubmed publisher
  106. Li R, Rezk A, Li H, Gommerman J, Prat A, Bar Or A. Antibody-Independent Function of Human B Cells Contributes to Antifungal T Cell Responses. J Immunol. 2017;198:3245-3254 pubmed publisher
  107. Cardinaud S, Urrutia A, Rouers A, Coulon P, Kervevan J, Richetta C, et al. Triggering of TLR-3, -4, NOD2, and DC-SIGN reduces viral replication and increases T-cell activation capacity of HIV-infected human dendritic cells. Eur J Immunol. 2017;47:818-829 pubmed publisher
  108. Eyquem J, Mansilla Soto J, Giavridis T, van der Stegen S, Hamieh M, Cunanan K, et al. Targeting a CAR to the TRAC locus with CRISPR/Cas9 enhances tumour rejection. Nature. 2017;543:113-117 pubmed publisher
  109. Szabo P, Goswami A, Mazzuca D, Kim K, O Gorman D, Hess D, et al. Rapid and Rigorous IL-17A Production by a Distinct Subpopulation of Effector Memory T Lymphocytes Constitutes a Novel Mechanism of Toxic Shock Syndrome Immunopathology. J Immunol. 2017;198:2805-2818 pubmed publisher
  110. Sullivan A, Wang E, Farrell J, Whitaker P, Faulkner L, Peckham D, et al. ?-Lactam hypersensitivity involves expansion of circulating and skin-resident TH22 cells. J Allergy Clin Immunol. 2018;141:235-249.e8 pubmed publisher
  111. Cheuk S, Schlums H, Gallais Sérézal I, Martini E, Chiang S, Marquardt N, et al. CD49a Expression Defines Tissue-Resident CD8+ T Cells Poised for Cytotoxic Function in Human Skin. Immunity. 2017;46:287-300 pubmed publisher
  112. Mordmuller B, Surat G, Lagler H, Chakravarty S, Ishizuka A, Lalremruata A, et al. Sterile protection against human malaria by chemoattenuated PfSPZ vaccine. Nature. 2017;542:445-449 pubmed publisher
  113. Mylvaganam G, Rios D, Abdelaal H, Iyer S, Tharp G, Mavigner M, et al. Dynamics of SIV-specific CXCR5+ CD8 T cells during chronic SIV infection. Proc Natl Acad Sci U S A. 2017;114:1976-1981 pubmed publisher
  114. Raposo R, de Mulder Rougvie M, Paquin Proulx D, Brailey P, Cabido V, Zdinak P, et al. IFITM1 targets HIV-1 latently infected cells for antibody-dependent cytolysis. JCI Insight. 2017;2:e85811 pubmed publisher
  115. Mufarrege E, Giorgetti S, Etcheverrigaray M, Terry F, Martin W, De Groot A. De-immunized and Functional Therapeutic (DeFT) versions of a long lasting recombinant alpha interferon for antiviral therapy. Clin Immunol. 2017;176:31-41 pubmed publisher
  116. Tauriainen J, Scharf L, Frederiksen J, Naji A, Ljunggren H, Sonnerborg A, et al. Perturbed CD8+ T cell TIGIT/CD226/PVR axis despite early initiation of antiretroviral treatment in HIV infected individuals. Sci Rep. 2017;7:40354 pubmed publisher
  117. Lundell A, Nordström I, Andersson K, Lundqvist C, Telemo E, Nava S, et al. IFN type I and II induce BAFF secretion from human decidual stromal cells. Sci Rep. 2017;7:39904 pubmed publisher
  118. Roberts E, Carnathan D, Li H, Shaw G, Silvestri G, Betts M. Collapse of Cytolytic Potential in SIV-Specific CD8+ T Cells Following Acute SIV Infection in Rhesus Macaques. PLoS Pathog. 2016;12:e1006135 pubmed publisher
  119. Stanfield B, Pahar B, Chouljenko V, Veazey R, Kousoulas K. Vaccination of rhesus macaques with the live-attenuated HSV-1 vaccine VC2 stimulates the proliferation of mucosal T cells and germinal center responses resulting in sustained production of highly neutralizing antibodies. Vaccine. 2017;35:536-543 pubmed publisher
  120. Izawa K, Martin E, Soudais C, Bruneau J, Boutboul D, Rodriguez R, et al. Inherited CD70 deficiency in humans reveals a critical role for the CD70-CD27 pathway in immunity to Epstein-Barr virus infection. J Exp Med. 2017;214:73-89 pubmed publisher
  121. Griffiths K, Ahmed M, Das S, Gopal R, Horne W, Connell T, et al. Targeting dendritic cells to accelerate T-cell activation overcomes a bottleneck in tuberculosis vaccine efficacy. Nat Commun. 2016;7:13894 pubmed publisher
  122. Cheng L, Ma J, Li J, Li D, Li G, Li F, et al. Blocking type I interferon signaling enhances T cell recovery and reduces HIV-1 reservoirs. J Clin Invest. 2017;127:269-279 pubmed publisher
  123. Lévy R, Okada S, Béziat V, Moriya K, Liu C, Chai L, et al. Genetic, immunological, and clinical features of patients with bacterial and fungal infections due to inherited IL-17RA deficiency. Proc Natl Acad Sci U S A. 2016;113:E8277-E8285 pubmed publisher
  124. Zhu H, Hu F, Sun X, Zhang X, Zhu L, Liu X, et al. CD16+ Monocyte Subset Was Enriched and Functionally Exacerbated in Driving T-Cell Activation and B-Cell Response in Systemic Lupus Erythematosus. Front Immunol. 2016;7:512 pubmed
  125. Ryan P, Sumaria N, Holland C, Bradford C, Izotova N, Grandjean C, et al. Heterogeneous yet stable Vδ2(+) T-cell profiles define distinct cytotoxic effector potentials in healthy human individuals. Proc Natl Acad Sci U S A. 2016;113:14378-14383 pubmed
  126. Tomic A, Varanasi P, Golemac M, Malic S, Riese P, Borst E, et al. Activation of Innate and Adaptive Immunity by a Recombinant Human Cytomegalovirus Strain Expressing an NKG2D Ligand. PLoS Pathog. 2016;12:e1006015 pubmed publisher
  127. Riou C, Bunjun R, Müller T, Kiravu A, Ginbot Z, Oni T, et al. Selective reduction of IFN-γ single positive mycobacteria-specific CD4+ T cells in HIV-1 infected individuals with latent tuberculosis infection. Tuberculosis (Edinb). 2016;101:25-30 pubmed publisher
  128. Hippen K, Watkins B, Tkachev V, Lemire A, Lehnen C, Riddle M, et al. Preclinical Testing of Antihuman CD28 Fab' Antibody in a Novel Nonhuman Primate Small Animal Rodent Model of Xenogenic Graft-Versus-Host Disease. Transplantation. 2016;100:2630-2639 pubmed publisher
  129. Li J, Shayan G, Avery L, Jie H, Gildener Leapman N, Schmitt N, et al. Tumor-infiltrating Tim-3+ T cells proliferate avidly except when PD-1 is co-expressed: Evidence for intracellular cross talk. Oncoimmunology. 2016;5:e1200778 pubmed
  130. Wu X, Wu X, Ma Y, Shao F, Tan Y, Tan T, et al. CUG-binding protein 1 regulates HSC activation and liver fibrogenesis. Nat Commun. 2016;7:13498 pubmed publisher
  131. Carroll R, Troelnikov A, Chong A. Virtual Global Transplant Laboratory Standard Operating Protocol for Donor Alloantigen-specific Interferon-gamma ELISPOT Assay. Transplant Direct. 2016;2:e111 pubmed
  132. Cuff A, Robertson F, Stegmann K, Pallett L, Maini M, Davidson B, et al. Eomeshi NK Cells in Human Liver Are Long-Lived and Do Not Recirculate but Can Be Replenished from the Circulation. J Immunol. 2016;197:4283-4291 pubmed
  133. van Haren S, Dowling D, Foppen W, Christensen D, Andersen P, Reed S, et al. Age-Specific Adjuvant Synergy: Dual TLR7/8 and Mincle Activation of Human Newborn Dendritic Cells Enables Th1 Polarization. J Immunol. 2016;197:4413-4424 pubmed
  134. Peters C, Häsler R, Wesch D, Kabelitz D. Human Vδ2 T cells are a major source of interleukin-9. Proc Natl Acad Sci U S A. 2016;113:12520-12525 pubmed
  135. Hu X, Valentin A, Dayton F, Kulkarni V, Alicea C, Rosati M, et al. DNA Prime-Boost Vaccine Regimen To Increase Breadth, Magnitude, and Cytotoxicity of the Cellular Immune Responses to Subdominant Gag Epitopes of Simian Immunodeficiency Virus and HIV. J Immunol. 2016;197:3999-4013 pubmed
  136. Chandele A, Sewatanon J, Gunisetty S, Singla M, Onlamoon N, Akondy R, et al. Characterization of Human CD8 T Cell Responses in Dengue Virus-Infected Patients from India. J Virol. 2016;90:11259-11278 pubmed
  137. Swaminathan G, Thoryk E, Cox K, Smith J, Wolf J, Gindy M, et al. A Tetravalent Sub-unit Dengue Vaccine Formulated with Ionizable Cationic Lipid Nanoparticle induces Significant Immune Responses in Rodents and Non-Human Primates. Sci Rep. 2016;6:34215 pubmed publisher
  138. Roybal K, Williams J, Morsut L, Rupp L, Kolinko I, Choe J, et al. Engineering T Cells with Customized Therapeutic Response Programs Using Synthetic Notch Receptors. Cell. 2016;167:419-432.e16 pubmed publisher
  139. Lu L, Chung A, Rosebrock T, Ghebremichael M, Yu W, Grace P, et al. A Functional Role for Antibodies in Tuberculosis. Cell. 2016;167:433-443.e14 pubmed publisher
  140. Wang Y, Ma C, Ling Y, Bousfiha A, Camcioglu Y, Jacquot S, et al. Dual T cell- and B cell-intrinsic deficiency in humans with biallelic RLTPR mutations. J Exp Med. 2016;213:2413-2435 pubmed
  141. Wahid R, Fresnay S, Levine M, Sztein M. Cross-reactive multifunctional CD4+ T cell responses against Salmonella enterica serovars Typhi, Paratyphi A and Paratyphi B in humans following immunization with live oral typhoid vaccine Ty21a. Clin Immunol. 2016;173:87-95 pubmed publisher
  142. Vargas Inchaustegui D, Ying O, Demberg T, Robert Guroff M. Evaluation of Functional NK Cell Responses in Vaccinated and SIV-Infected Rhesus Macaques. Front Immunol. 2016;7:340 pubmed publisher
  143. Tagawa T, Albanese M, Bouvet M, Moosmann A, Mautner J, Heissmeyer V, et al. Epstein-Barr viral miRNAs inhibit antiviral CD4+ T cell responses targeting IL-12 and peptide processing. J Exp Med. 2016;213:2065-80 pubmed publisher
  144. Pachnio A, Ciáurriz M, Begum J, Lal N, Zuo J, Beggs A, et al. Cytomegalovirus Infection Leads to Development of High Frequencies of Cytotoxic Virus-Specific CD4+ T Cells Targeted to Vascular Endothelium. PLoS Pathog. 2016;12:e1005832 pubmed publisher
  145. Ayala V, Trivett M, Barsov E, Jain S, Piatak M, Trubey C, et al. Adoptive Transfer of Engineered Rhesus Simian Immunodeficiency Virus-Specific CD8+ T Cells Reduces the Number of Transmitted/Founder Viruses Established in Rhesus Macaques. J Virol. 2016;90:9942-9952 pubmed publisher
  146. Kagoya Y, Nakatsugawa M, Yamashita Y, Ochi T, Guo T, Anczurowski M, et al. BET bromodomain inhibition enhances T cell persistence and function in adoptive immunotherapy models. J Clin Invest. 2016;126:3479-94 pubmed publisher
  147. La Porta J, Matus Nicodemos R, Valentin Acevedo A, Covey L. The RNA-Binding Protein, Polypyrimidine Tract-Binding Protein 1 (PTBP1) Is a Key Regulator of CD4 T Cell Activation. PLoS ONE. 2016;11:e0158708 pubmed publisher
  148. Hervier B, Perez M, Allenbach Y, Devilliers H, Cohen F, Uzunhan Y, et al. Involvement of NK Cells and NKp30 Pathway in Antisynthetase Syndrome. J Immunol. 2016;197:1621-30 pubmed publisher
  149. He R, Hou S, Liu C, Zhang A, Bai Q, Han M, et al. Follicular CXCR5- expressing CD8(+) T cells curtail chronic viral infection. Nature. 2016;537:412-428 pubmed publisher
  150. Xing Y, Cao R, Hu H. TLR and NLRP3 inflammasome-dependent innate immune responses to tumor-derived autophagosomes (DRibbles). Cell Death Dis. 2016;7:e2322 pubmed publisher
  151. Dahal L, Basu N, Youssef H, Khanolkar R, Barker R, Erwig L, et al. Immunoregulatory soluble CTLA-4 modifies effector T-cell responses in systemic lupus erythematosus. Arthritis Res Ther. 2016;18:180 pubmed publisher
  152. Demers K, Makedonas G, Buggert M, Eller M, Ratcliffe S, Goonetilleke N, et al. Temporal Dynamics of CD8+ T Cell Effector Responses during Primary HIV Infection. PLoS Pathog. 2016;12:e1005805 pubmed publisher
  153. Kritikou J, Dahlberg C, Baptista M, Wagner A, Banerjee P, Gwalani L, et al. IL-2 in the tumor microenvironment is necessary for Wiskott-Aldrich syndrome protein deficient NK cells to respond to tumors in vivo. Sci Rep. 2016;6:30636 pubmed publisher
  154. Rölle A, Halenius A, Ewen E, Cerwenka A, Hengel H, Momburg F. CD2-CD58 interactions are pivotal for the activation and function of adaptive natural killer cells in human cytomegalovirus infection. Eur J Immunol. 2016;46:2420-2425 pubmed publisher
  155. Franzese O, Palermo B, Di Donna C, Sperduti I, Ferraresi V, Stabile H, et al. Polyfunctional Melan-A-specific tumor-reactive CD8(+) T cells elicited by dacarbazine treatment before peptide-vaccination depends on AKT activation sustained by ICOS. Oncoimmunology. 2016;5:e1114203 pubmed publisher
  156. Peper J, Bösmüller H, Schuster H, Gückel B, Hörzer H, Roehle K, et al. HLA ligandomics identifies histone deacetylase 1 as target for ovarian cancer immunotherapy. Oncoimmunology. 2016;5:e1065369 pubmed publisher
  157. Neumann L, Mueller M, Moos V, Heller F, Meyer T, Loddenkemper C, et al. Mucosal Inducible NO Synthase-Producing IgA+ Plasma Cells in Helicobacter pylori-Infected Patients. J Immunol. 2016;197:1801-8 pubmed publisher
  158. Sadallah S, Schmied L, Eken C, Charoudeh H, Amicarella F, Schifferli J. Platelet-Derived Ectosomes Reduce NK Cell Function. J Immunol. 2016;197:1663-71 pubmed publisher
  159. Suliman S, Geldenhuys H, Johnson J, Hughes J, Smit E, Murphy M, et al. Bacillus Calmette-Guérin (BCG) Revaccination of Adults with Latent Mycobacterium tuberculosis Infection Induces Long-Lived BCG-Reactive NK Cell Responses. J Immunol. 2016;197:1100-1110 pubmed publisher
  160. Di Liberto D, Mansueto P, D Alcamo A, Lo Pizzo M, Lo Presti E, Geraci G, et al. Predominance of Type 1 Innate Lymphoid Cells in the Rectal Mucosa of Patients With Non-Celiac Wheat Sensitivity: Reversal After a Wheat-Free Diet. Clin Transl Gastroenterol. 2016;7:e178 pubmed publisher
  161. van Wilgenburg B, Scherwitzl I, Hutchinson E, Leng T, Kurioka A, Kulicke C, et al. MAIT cells are activated during human viral infections. Nat Commun. 2016;7:11653 pubmed publisher
  162. Cheng W, van Asten S, Burns L, Evans H, Walter G, Hashim A, et al. Periodontitis-associated pathogens P. gingivalis and A. actinomycetemcomitans activate human CD14(+) monocytes leading to enhanced Th17/IL-17 responses. Eur J Immunol. 2016;46:2211-21 pubmed publisher
  163. Heath J, Newhook N, Comeau E, Gallant M, Fudge N, Grant M. NKG2C(+)CD57(+) Natural Killer Cell Expansion Parallels Cytomegalovirus-Specific CD8(+) T Cell Evolution towards Senescence. J Immunol Res. 2016;2016:7470124 pubmed publisher
  164. Arbore G, West E, Spolski R, Robertson A, Klos A, Rheinheimer C, et al. T helper 1 immunity requires complement-driven NLRP3 inflammasome activity in CD4⁺ T cells. Science. 2016;352:aad1210 pubmed publisher
  165. Coulon P, Richetta C, Rouers A, Blanchet F, Urrutia A, Guerbois M, et al. HIV-Infected Dendritic Cells Present Endogenous MHC Class II-Restricted Antigens to HIV-Specific CD4+ T Cells. J Immunol. 2016;197:517-32 pubmed publisher
  166. Li C, Zhang Y, Tang L, Zhao H, Gao C, Gao L, et al. Expression of factors involved in the regulation of angiogenesis in the full-term human placenta: Effects of in vitro fertilization. Reprod Biol. 2016;16:104-12 pubmed publisher
  167. Domingues R, de Carvalho G, Aoki V, da Silva Duarte A, Sato M. Activation of myeloid dendritic cells, effector cells and regulatory T cells in lichen planus. J Transl Med. 2016;14:171 pubmed publisher
  168. Zanetti S, Ziblat A, Torres N, Zwirner N, Bouzat C. Expression and Functional Role of ?7 Nicotinic Receptor in Human Cytokine-stimulated Natural Killer (NK) Cells. J Biol Chem. 2016;291:16541-52 pubmed publisher
  169. Kranz L, Diken M, Haas H, Kreiter S, Loquai C, Reuter K, et al. Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy. Nature. 2016;534:396-401 pubmed publisher
  170. Vaccari M, Gordon S, Fourati S, Schifanella L, Liyanage N, Cameron M, et al. Adjuvant-dependent innate and adaptive immune signatures of risk of SIVmac251 acquisition. Nat Med. 2016;22:762-70 pubmed publisher
  171. Loyon R, Picard E, Mauvais O, Queiroz L, Mougey V, Pallandre J, et al. IL-21-Induced MHC Class II+ NK Cells Promote the Expansion of Human Uncommitted CD4+ Central Memory T Cells in a Macrophage Migration Inhibitory Factor-Dependent Manner. J Immunol. 2016;197:85-96 pubmed publisher
  172. Goodier M, Rodríguez Galán A, Lusa C, Nielsen C, Darboe A, Moldoveanu A, et al. Influenza Vaccination Generates Cytokine-Induced Memory-like NK Cells: Impact of Human Cytomegalovirus Infection. J Immunol. 2016;197:313-25 pubmed publisher
  173. Kwon H, Choi G, Ryu S, Kwon S, Kim S, Booth C, et al. Stepwise phosphorylation of p65 promotes NF-?B activation and NK cell responses during target cell recognition. Nat Commun. 2016;7:11686 pubmed publisher
  174. Neumann B, Shi T, Gan L, Klippert A, Daskalaki M, Stolte Leeb N, et al. Comprehensive panel of cross-reacting monoclonal antibodies for analysis of different immune cells and their distribution in the common marmoset (Callithrix jacchus). J Med Primatol. 2016;45:139-46 pubmed publisher
  175. Li W, Liu L, Gomez A, Zhang J, Ramadan A, Zhang Q, et al. Proteomics analysis reveals a Th17-prone cell population in presymptomatic graft-versus-host disease. JCI Insight. 2016;1: pubmed publisher
  176. Yin W, Tong S, Zhang Q, Shao J, Liu Q, Peng H, et al. Functional dichotomy of Vδ2 γδ T cells in chronic hepatitis C virus infections: role in cytotoxicity but not for IFN-γ production. Sci Rep. 2016;6:26296 pubmed publisher
  177. Kay A, Strauss Albee D, Blish C. Application of Mass Cytometry (CyTOF) for Functional and Phenotypic Analysis of Natural Killer Cells. Methods Mol Biol. 2016;1441:13-26 pubmed publisher
  178. Stikvoort A, Sundin M, Uzunel M, Gertow J, Sundberg B, Schaffer M, et al. Long-Term Stable Mixed Chimerism after Hematopoietic Stem Cell Transplantation in Patients with Non-Malignant Disease, Shall We Be Tolerant?. PLoS ONE. 2016;11:e0154737 pubmed publisher
  179. Qualai J, Li L, Cantero J, Tarrats A, Fernández M, Sumoy L, et al. Expression of CD11c Is Associated with Unconventional Activated T Cell Subsets with High Migratory Potential. PLoS ONE. 2016;11:e0154253 pubmed publisher
  180. Bal S, Bernink J, Nagasawa M, Groot J, Shikhagaie M, Golebski K, et al. IL-1?, IL-4 and IL-12 control the fate of group 2 innate lymphoid cells in human airway inflammation in the lungs. Nat Immunol. 2016;17:636-45 pubmed publisher
  181. Graves S, Kouriba B, Diarra I, Daou M, Niangaly A, Coulibaly D, et al. Strain-specific Plasmodium falciparum multifunctional CD4(+) T cell cytokine expression in Malian children immunized with the FMP2.1/AS02A vaccine candidate. Vaccine. 2016;34:2546-55 pubmed publisher
  182. Zurawski G, Zurawski S, Flamar A, Richert L, Wagner R, Tomaras G, et al. Targeting HIV-1 Env gp140 to LOX-1 Elicits Immune Responses in Rhesus Macaques. PLoS ONE. 2016;11:e0153484 pubmed publisher
  183. Dimitrova M, Zenarruzabeitia O, Borrego F, Simhadri V. CD300c is uniquely expressed on CD56 bright Natural Killer Cells and differs from CD300a upon ligand recognition. Sci Rep. 2016;6:23942 pubmed publisher
  184. Rueda C, Presicce P, Jackson C, Miller L, Kallapur S, Jobe A, et al. Lipopolysaccharide-Induced Chorioamnionitis Promotes IL-1-Dependent Inflammatory FOXP3+ CD4+ T Cells in the Fetal Rhesus Macaque. J Immunol. 2016;196:3706-15 pubmed publisher
  185. Gielen P, Schulte B, Kers Rebel E, Verrijp K, Bossman S, ter Laan M, et al. Elevated levels of polymorphonuclear myeloid-derived suppressor cells in patients with glioblastoma highly express S100A8/9 and arginase and suppress T cell function. Neuro Oncol. 2016;18:1253-64 pubmed publisher
  186. Macdonald K, Hoeppli R, Huang Q, Gillies J, Luciani D, Orban P, et al. Alloantigen-specific regulatory T cells generated with a chimeric antigen receptor. J Clin Invest. 2016;126:1413-24 pubmed publisher
  187. Carrasco A, Fernández Bañares F, Pedrosa E, Salas A, Loras C, Rosinach M, et al. Regional Specialisation of T Cell Subsets and Apoptosis in the Human Gut Mucosa: Differences Between Ileum and Colon in Healthy Intestine and Inflammatory Bowel Diseases. J Crohns Colitis. 2016;10:1042-54 pubmed publisher
  188. Gao J, Duan Z, Zhang L, Huang X, Long L, Tu J, et al. Failure recovery of circulating NKG2D+CD56dimNK cells in HBV-associated hepatocellular carcinoma after hepatectomy predicts early recurrence. Oncoimmunology. 2016;5:e1048061 pubmed
  189. Fisher J, Flutter B, Wesemann F, Frosch J, Rossig C, Gustafsson K, et al. Effective combination treatment of GD2-expressing neuroblastoma and Ewing's sarcoma using anti-GD2 ch14.18/CHO antibody with Vγ9Vδ2+ γδT cells. Oncoimmunology. 2016;5:e1025194 pubmed
  190. Carrasco A, Esteve M, Salas A, Pedrosa E, Rosinach M, Aceituno M, et al. Immunological Differences between Lymphocytic and Collagenous Colitis. J Crohns Colitis. 2016;10:1055-66 pubmed publisher
  191. Offersen R, Nissen S, Rasmussen T, Østergaard L, Denton P, Søgaard O, et al. A Novel Toll-Like Receptor 9 Agonist, MGN1703, Enhances HIV-1 Transcription and NK Cell-Mediated Inhibition of HIV-1-Infected Autologous CD4+ T Cells. J Virol. 2016;90:4441-4453 pubmed publisher
  192. Phuah J, Wong E, Gideon H, Maiello P, Coleman M, Hendricks M, et al. Effects of B Cell Depletion on Early Mycobacterium tuberculosis Infection in Cynomolgus Macaques. Infect Immun. 2016;84:1301-1311 pubmed publisher
  193. Vallera D, Felices M, McElmurry R, McCullar V, Zhou X, Schmohl J, et al. IL15 Trispecific Killer Engagers (TriKE) Make Natural Killer Cells Specific to CD33+ Targets While Also Inducing Persistence, In Vivo Expansion, and Enhanced Function. Clin Cancer Res. 2016;22:3440-50 pubmed publisher
  194. Roan F, Stoklasek T, Whalen E, Molitor J, Bluestone J, Buckner J, et al. CD4+ Group 1 Innate Lymphoid Cells (ILC) Form a Functionally Distinct ILC Subset That Is Increased in Systemic Sclerosis. J Immunol. 2016;196:2051-2062 pubmed publisher
  195. Cao Y, Amezquita R, Kleinstein S, Stathopoulos P, Nowak R, O Connor K. Autoreactive T Cells from Patients with Myasthenia Gravis Are Characterized by Elevated IL-17, IFN-γ, and GM-CSF and Diminished IL-10 Production. J Immunol. 2016;196:2075-84 pubmed publisher
  196. James E, Gates T, LaFond R, Yamamoto S, Ni C, Mai D, et al. Neuroinvasive West Nile Infection Elicits Elevated and Atypically Polarized T Cell Responses That Promote a Pathogenic Outcome. PLoS Pathog. 2016;12:e1005375 pubmed publisher
  197. Tham M, Schlör G, Yerly D, Mueller C, Surbek D, Villiger P, et al. Reduced pro-inflammatory profile of γδT cells in pregnant patients with rheumatoid arthritis. Arthritis Res Ther. 2016;18:26 pubmed publisher
  198. Li L, Jiang Y, Lao S, Yang B, Yu S, Zhang Y, et al. Mycobacterium tuberculosis-Specific IL-21+IFN-γ+CD4+ T Cells Are Regulated by IL-12. PLoS ONE. 2016;11:e0147356 pubmed publisher
  199. Di Meglio P, Villanova F, Navarini A, Mylonas A, Tosi I, Nestle F, et al. Targeting CD8(+) T cells prevents psoriasis development. J Allergy Clin Immunol. 2016;138:274-276.e6 pubmed publisher
  200. Lood C, Blanco L, Purmalek M, Carmona Rivera C, De Ravin S, Smith C, et al. Neutrophil extracellular traps enriched in oxidized mitochondrial DNA are interferogenic and contribute to lupus-like disease. Nat Med. 2016;22:146-53 pubmed publisher
  201. Bjerg Christensen A, Dige A, Vad Nielsen J, Brinkmann C, Bendix M, Østergaard L, et al. Administration of Panobinostat Is Associated with Increased IL-17A mRNA in the Intestinal Epithelium of HIV-1 Patients. Mediators Inflamm. 2015;2015:120605 pubmed publisher
  202. Paris R, Petrovas C, Ferrando Martinez S, Moysi E, Boswell K, Archer E, et al. Selective Loss of Early Differentiated, Highly Functional PD1high CD4 T Cells with HIV Progression. PLoS ONE. 2015;10:e0144767 pubmed publisher
  203. Lee W, Richard J, Lichtfuss M, Smith A, Park J, Courter J, et al. Antibody-Dependent Cellular Cytotoxicity against Reactivated HIV-1-Infected Cells. J Virol. 2016;90:2021-30 pubmed publisher
  204. Cleret Buhot A, Zhang Y, Planas D, Goulet J, Monteiro P, Gosselin A, et al. Identification of novel HIV-1 dependency factors in primary CCR4(+)CCR6(+)Th17 cells via a genome-wide transcriptional approach. Retrovirology. 2015;12:102 pubmed publisher
  205. Woodfolk J, Glesner J, Wright P, Kepley C, Li M, Himly M, et al. Antigenic Determinants of the Bilobal Cockroach Allergen Bla g 2. J Biol Chem. 2016;291:2288-301 pubmed publisher
  206. Wu F, Wang L, Guo Q, Zhao M, Gu H, Xu H, et al. A Homogeneous Immunoassay Method for Detecting Interferon-Gamma in Patients with Latent Tuberculosis Infection. J Microbiol Biotechnol. 2016;26:588-95 pubmed publisher
  207. Bolton D, Pegu A, Wang K, McGinnis K, Nason M, Foulds K, et al. Human Immunodeficiency Virus Type 1 Monoclonal Antibodies Suppress Acute Simian-Human Immunodeficiency Virus Viremia and Limit Seeding of Cell-Associated Viral Reservoirs. J Virol. 2016;90:1321-32 pubmed publisher
  208. Eskicioğlu F, Özdemir A, Özdemir R, Turan G, Akan Z, Hasdemir S. The association of HLA-G and immune markers in recurrent miscarriages. J Matern Fetal Neonatal Med. 2016;29:3056-60 pubmed publisher
  209. van Nierop G, Janssen M, Mitterreiter J, van de Vijver D, De Swart R, Haagmans B, et al. Intrathecal CD4(+) and CD8(+) T-cell responses to endogenously synthesized candidate disease-associated human autoantigens in multiple sclerosis patients. Eur J Immunol. 2016;46:347-53 pubmed publisher
  210. Scottà C, Fanelli G, Hoong S, Romano M, Lamperti E, Sukthankar M, et al. Impact of immunosuppressive drugs on the therapeutic efficacy of ex vivo expanded human regulatory T cells. Haematologica. 2016;101:91-100 pubmed publisher
  211. Schulz A, Mälzer J, Domingo C, Jürchott K, Grützkau A, Babel N, et al. Low Thymic Activity and Dendritic Cell Numbers Are Associated with the Immune Response to Primary Viral Infection in Elderly Humans. J Immunol. 2015;195:4699-711 pubmed publisher
  212. Simonetta F, Pradier A, Bosshard C, Masouridi Levrat S, Chalandon Y, Roosnek E. NK Cell Functional Impairment after Allogeneic Hematopoietic Stem Cell Transplantation Is Associated with Reduced Levels of T-bet and Eomesodermin. J Immunol. 2015;195:4712-20 pubmed publisher
  213. Rosario M, Liu B, Kong L, Collins L, Schneider S, Chen X, et al. The IL-15-Based ALT-803 Complex Enhances FcγRIIIa-Triggered NK Cell Responses and In Vivo Clearance of B Cell Lymphomas. Clin Cancer Res. 2016;22:596-608 pubmed publisher
  214. Berinstein N, Karkada M, Oza A, Odunsi K, Villella J, Nemunaitis J, et al. Survivin-targeted immunotherapy drives robust polyfunctional T cell generation and differentiation in advanced ovarian cancer patients. Oncoimmunology. 2015;4:e1026529 pubmed
  215. Moreira M, Dorneles E, Soares R, Magalhães C, Costa Pereira C, Lage A, et al. Cross-reactivity of commercially available anti-human monoclonal antibodies with canine cytokines: establishment of a reliable panel to detect the functional profile of peripheral blood lymphocytes by intracytoplasmic staining. Acta Vet Scand. 2015;57:51 pubmed publisher
  216. Campi Azevedo A, Costa Pereira C, Antonelli L, Fonseca C, Teixeira Carvalho A, Villela Rezende G, et al. Booster dose after 10 years is recommended following 17DD-YF primary vaccination. Hum Vaccin Immunother. 2016;12:491-502 pubmed publisher
  217. Leeansyah E, Svärd J, Dias J, Buggert M, Nyström J, Quigley M, et al. Arming of MAIT Cell Cytolytic Antimicrobial Activity Is Induced by IL-7 and Defective in HIV-1 Infection. PLoS Pathog. 2015;11:e1005072 pubmed publisher
  218. Zhu F, Qiao J, Cao J, Sun H, Wu Q, Sun Z, et al. Decreased level of cytotoxic T lymphocyte antigen-4 (CTLA-4) in patients with acute immune thrombocytopenia (ITP). Thromb Res. 2015;136:797-802 pubmed publisher
  219. Weist B, Wehler P, El Ahmad L, Schmueck Henneresse M, Millward J, Nienen M, et al. A revised strategy for monitoring BKV-specific cellular immunity in kidney transplant patients. Kidney Int. 2015;88:1293-1303 pubmed publisher
  220. Schnorfeil F, Lichtenegger F, Emmerig K, Schlueter M, Neitz J, Draenert R, et al. T cells are functionally not impaired in AML: increased PD-1 expression is only seen at time of relapse and correlates with a shift towards the memory T cell compartment. J Hematol Oncol. 2015;8:93 pubmed publisher
  221. Riou C, Tanko R, Soares A, Masson L, Werner L, Garrett N, et al. Restoration of CD4+ Responses to Copathogens in HIV-Infected Individuals on Antiretroviral Therapy Is Dependent on T Cell Memory Phenotype. J Immunol. 2015;195:2273-2281 pubmed publisher
  222. Wang Y, Zhong H, Xie X, Chen C, Huang D, Shen L, et al. Long noncoding RNA derived from CD244 signaling epigenetically controls CD8+ T-cell immune responses in tuberculosis infection. Proc Natl Acad Sci U S A. 2015;112:E3883-92 pubmed publisher
  223. Adoro S, Cubillos Ruiz J, Chen X, Deruaz M, Vrbanac V, Song M, et al. IL-21 induces antiviral microRNA-29 in CD4 T cells to limit HIV-1 infection. Nat Commun. 2015;6:7562 pubmed publisher
  224. Yawata N, Selva K, Liu Y, Tan K, Lee A, Siak J, et al. Dynamic change in natural killer cell type in the human ocular mucosa in situ as means of immune evasion by adenovirus infection. Mucosal Immunol. 2016;9:159-70 pubmed publisher
  225. Chowdhury A, Hayes T, Bosinger S, Lawson B, Vanderford T, Schmitz J, et al. Differential Impact of In Vivo CD8+ T Lymphocyte Depletion in Controller versus Progressor Simian Immunodeficiency Virus-Infected Macaques. J Virol. 2015;89:8677-86 pubmed publisher
  226. Chang D, Moniz R, Xu Z, Sun J, Signoretti S, Zhu Q, et al. Human anti-CAIX antibodies mediate immune cell inhibition of renal cell carcinoma in vitro and in a humanized mouse model in vivo. Mol Cancer. 2015;14:119 pubmed publisher
  227. Boisson B, Laplantine E, Dobbs K, Cobat A, Tarantino N, Hazen M, et al. Human HOIP and LUBAC deficiency underlies autoinflammation, immunodeficiency, amylopectinosis, and lymphangiectasia. J Exp Med. 2015;212:939-51 pubmed publisher
  228. Wang Z, Wan Y, Qiu C, Quiñones Parra S, Zhu Z, Loh L, et al. Recovery from severe H7N9 disease is associated with diverse response mechanisms dominated by CD8⁺ T cells. Nat Commun. 2015;6:6833 pubmed publisher
  229. Boer M, Prins C, van Meijgaarden K, van Dissel J, Ottenhoff T, Joosten S. Mycobacterium bovis BCG Vaccination Induces Divergent Proinflammatory or Regulatory T Cell Responses in Adults. Clin Vaccine Immunol. 2015;22:778-88 pubmed publisher
  230. Kinder M, Greenplate A, Strohl W, Jordan R, Brezski R. An Fc engineering approach that modulates antibody-dependent cytokine release without altering cell-killing functions. MAbs. 2015;7:494-504 pubmed publisher
  231. Lee J, Jeong I, Joh J, Jung Y, Sim S, Choi B, et al. Differential expression of CD57 in antigen-reactive CD4+ T cells between active and latent tuberculosis infection. Clin Immunol. 2015;159:37-46 pubmed publisher
  232. Riccio E, Pratt Riccio L, Bianco Júnior C, Sanchez V, Totino P, Carvalho L, et al. Molecular and immunological tools for the evaluation of the cellular immune response in the neotropical monkey Saimiri sciureus, a non-human primate model for malaria research. Malar J. 2015;14:166 pubmed publisher
  233. DaFonseca S, Niessl J, Pouvreau S, Wacleche V, Gosselin A, Cleret Buhot A, et al. Impaired Th17 polarization of phenotypically naive CD4(+) T-cells during chronic HIV-1 infection and potential restoration with early ART. Retrovirology. 2015;12:38 pubmed publisher
  234. Lenz N, Schindler T, Kagina B, Zhang J, Lukindo T, Mpina M, et al. Antiviral Innate Immune Activation in HIV-Infected Adults Negatively Affects H1/IC31-Induced Vaccine-Specific Memory CD4+ T Cells. Clin Vaccine Immunol. 2015;22:688-96 pubmed publisher
  235. Schmueck Henneresse M, Sharaf R, Vogt K, Weist B, Landwehr Kenzel S, Fuehrer H, et al. Peripheral blood-derived virus-specific memory stem T cells mature to functional effector memory subsets with self-renewal potency. J Immunol. 2015;194:5559-67 pubmed publisher
  236. Dyring Andersen B, Bonefeld C, Bzorek M, Løvendorf M, Lauritsen J, Skov L, et al. The Vitamin D Analogue Calcipotriol Reduces the Frequency of CD8+ IL-17+ T Cells in Psoriasis Lesions. Scand J Immunol. 2015;82:84-91 pubmed publisher
  237. Wu Z, Frascaroli G, Bayer C, Schmal T, Mertens T. Interleukin-2 from Adaptive T Cells Enhances Natural Killer Cell Activity against Human Cytomegalovirus-Infected Macrophages. J Virol. 2015;89:6435-41 pubmed publisher
  238. Zhou J, Amran F, Kramski M, Angelovich T, Elliott J, Hearps A, et al. An NK Cell Population Lacking FcRγ Is Expanded in Chronically Infected HIV Patients. J Immunol. 2015;194:4688-97 pubmed publisher
  239. Xu M, Chen X, Yin H, Yin L, Liu F, Fu Y, et al. Cloning and characterization of the human integrin β6 gene promoter. PLoS ONE. 2015;10:e0121439 pubmed publisher
  240. Trabanelli S, Lecciso M, Salvestrini V, Cavo M, Očadlíková D, Lemoli R, et al. PGE2-induced IDO1 inhibits the capacity of fully mature DCs to elicit an in vitro antileukemic immune response. J Immunol Res. 2015;2015:253191 pubmed publisher
  241. Hong M, Sandalova E, Low D, Gehring A, Fieni S, Amadei B, et al. Trained immunity in newborn infants of HBV-infected mothers. Nat Commun. 2015;6:6588 pubmed publisher
  242. Misra R, Shah S, Fowell D, Wang H, Scheible K, Misra S, et al. Preterm cord blood CD4⁺ T cells exhibit increased IL-6 production in chorioamnionitis and decreased CD4⁺ T cells in bronchopulmonary dysplasia. Hum Immunol. 2015;76:329-338 pubmed publisher
  243. Bradley S, Chen Z, Melendez B, Talukder A, Khalili J, Rodríguez Cruz T, et al. BRAFV600E Co-opts a Conserved MHC Class I Internalization Pathway to Diminish Antigen Presentation and CD8+ T-cell Recognition of Melanoma. Cancer Immunol Res. 2015;3:602-9 pubmed publisher
  244. Ohnuma K, Hatano R, Aune T, Otsuka H, Iwata S, Dang N, et al. Regulation of pulmonary graft-versus-host disease by IL-26+CD26+CD4 T lymphocytes. J Immunol. 2015;194:3697-712 pubmed publisher
  245. Laing K, Russell R, Dong L, Schmid D, Stern M, Magaret A, et al. Zoster Vaccination Increases the Breadth of CD4+ T Cells Responsive to Varicella Zoster Virus. J Infect Dis. 2015;212:1022-31 pubmed publisher
  246. Obiero J, Shekalaghe S, Hermsen C, Mpina M, Bijker E, Roestenberg M, et al. Impact of malaria preexposure on antiparasite cellular and humoral immune responses after controlled human malaria infection. Infect Immun. 2015;83:2185-96 pubmed publisher
  247. Chen M, Hu P, Ling N, Peng H, Lei Y, Hu H, et al. Enhanced functions of peripheral γδ T cells in chronic hepatitis B infection during interferon α treatment in vivo and in vitro. PLoS ONE. 2015;10:e0120086 pubmed publisher
  248. Bowcutt R, Malter L, Chen L, Wolff M, Robertson I, Rifkin D, et al. Isolation and cytokine analysis of lamina propria lymphocytes from mucosal biopsies of the human colon. J Immunol Methods. 2015;421:27-35 pubmed publisher
  249. Steindor M, Nkwouano V, Mayatepek E, Mackenzie C, Schramm D, Jacobsen M. Rapid detection and immune characterization of Mycobacterium abscessus infection in cystic fibrosis patients. PLoS ONE. 2015;10:e0119737 pubmed publisher
  250. Tsai C, Liong K, Gunalan M, Li N, Lim D, Fisher D, et al. Type I IFNs and IL-18 regulate the antiviral response of primary human γδ T cells against dendritic cells infected with Dengue virus. J Immunol. 2015;194:3890-900 pubmed publisher
  251. Rodriguez J, Marchicio J, López M, Ziblat A, Elias F, Fló J, et al. PyNTTTTGT and CpG immunostimulatory oligonucleotides: effect on granulocyte/monocyte colony-stimulating factor (GM-CSF) secretion by human CD56+ (NK and NKT) cells. PLoS ONE. 2015;10:e0117484 pubmed publisher
  252. Severson J, Serracino H, Mateescu V, Raeburn C, McIntyre R, Sams S, et al. PD-1+Tim-3+ CD8+ T Lymphocytes Display Varied Degrees of Functional Exhaustion in Patients with Regionally Metastatic Differentiated Thyroid Cancer. Cancer Immunol Res. 2015;3:620-30 pubmed publisher
  253. Lu Y, Xue Q, Eisele M, Sulistijo E, Brower K, Han L, et al. Highly multiplexed profiling of single-cell effector functions reveals deep functional heterogeneity in response to pathogenic ligands. Proc Natl Acad Sci U S A. 2015;112:E607-15 pubmed publisher
  254. Rissiek A, Baumann I, Cuapio A, Mautner A, Kolster M, Arck P, et al. The expression of CD39 on regulatory T cells is genetically driven and further upregulated at sites of inflammation. J Autoimmun. 2015;58:12-20 pubmed publisher
  255. Triplett T, Tucker C, Triplett K, Alderman Z, Sun L, Ling L, et al. STAT3 Signaling Is Required for Optimal Regression of Large Established Tumors in Mice Treated with Anti-OX40 and TGFβ Receptor Blockade. Cancer Immunol Res. 2015;3:526-35 pubmed publisher
  256. Dimova T, Brouwer M, Gosselin F, Tassignon J, Leo O, Donner C, et al. Effector Vγ9Vδ2 T cells dominate the human fetal γδ T-cell repertoire. Proc Natl Acad Sci U S A. 2015;112:E556-65 pubmed publisher
  257. Bourgeois E, Subramaniam S, Cheng T, de Jong A, Layre E, Ly D, et al. Bee venom processes human skin lipids for presentation by CD1a. J Exp Med. 2015;212:149-63 pubmed publisher
  258. Karlsson F, Hassan Zahraee M. Quantification of Th1 and Th17 Cells with Intracellular Staining Following PMA/Ionomycin Stimulation. Curr Protoc Cytom. 2015;71:6.35.1-7 pubmed publisher
  259. Li F, Ji L, Wang W, Hua F, Zhan Y, Zou S, et al. Insufficient secretion of IL-10 by Tregs compromised its control on over-activated CD4+ T effector cells in newly diagnosed adult immune thrombocytopenia patients. Immunol Res. 2015;61:269-80 pubmed publisher
  260. Hatano R, Ohnuma K, Otsuka H, Komiya E, Taki I, Iwata S, et al. CD26-mediated induction of EGR2 and IL-10 as potential regulatory mechanism for CD26 costimulatory pathway. J Immunol. 2015;194:960-72 pubmed publisher
  261. Touzot M, Cacoub P, Bodaghi B, Soumelis V, Saadoun D. IFN-α induces IL-10 production and tilt the balance between Th1 and Th17 in Behçet disease. Autoimmun Rev. 2015;14:370-5 pubmed publisher
  262. Nguyen L, Pan J, Dinh T, Hadeiba H, O Hara E, Ebtikar A, et al. Role and species-specific expression of colon T cell homing receptor GPR15 in colitis. Nat Immunol. 2015;16:207-213 pubmed publisher
  263. Kagina B, Mansoor N, Kpamegan E, Penn Nicholson A, Nemes E, Smit E, et al. Qualification of a whole blood intracellular cytokine staining assay to measure mycobacteria-specific CD4 and CD8 T cell immunity by flow cytometry. J Immunol Methods. 2015;417:22-33 pubmed publisher
  264. Heninger A, Wentrup S, Al Saeedi M, Schiessling S, Giese T, Wartha F, et al. Immunomodulation of human intestinal T cells by the synthetic CD80 antagonist RhuDex®. Immun Inflamm Dis. 2014;2:166-80 pubmed publisher
  265. Bürgler S, Gimeno A, Parente Ribes A, Wang D, Os A, Devereux S, et al. Chronic lymphocytic leukemia cells express CD38 in response to Th1 cell-derived IFN-γ by a T-bet-dependent mechanism. J Immunol. 2015;194:827-35 pubmed publisher
  266. Setoguchi R, Matsui Y, Mouri K. mTOR signaling promotes a robust and continuous production of IFN-γ by human memory CD8+ T cells and their proliferation. Eur J Immunol. 2015;45:893-902 pubmed publisher
  267. Van Eyck L, Hershfield M, Pombal D, Kelly S, Ganson N, Moens L, et al. Hematopoietic stem cell transplantation rescues the immunologic phenotype and prevents vasculopathy in patients with adenosine deaminase 2 deficiency. J Allergy Clin Immunol. 2015;135:283-7.e5 pubmed publisher
  268. Zhang P, Lu X, Tao K, Shi L, Li W, Wang G, et al. Siglec-10 is associated with survival and natural killer cell dysfunction in hepatocellular carcinoma. J Surg Res. 2015;194:107-13 pubmed publisher
  269. Hautefort A, Girerd B, Montani D, Cohen Kaminsky S, Price L, Lambrecht B, et al. T-helper 17 cell polarization in pulmonary arterial hypertension. Chest. 2015;147:1610-1620 pubmed publisher
  270. Rovetta A, Peña D, Hernández Del Pino R, Recalde G, Pellegrini J, Bigi F, et al. IFNG-mediated immune responses enhance autophagy against Mycobacterium tuberculosis antigens in patients with active tuberculosis. Autophagy. 2014;10:2109-21 pubmed publisher
  271. Huss D, Mehta D, Sharma A, You X, Riester K, Sheridan J, et al. In vivo maintenance of human regulatory T cells during CD25 blockade. J Immunol. 2015;194:84-92 pubmed
  272. Dominguez Villar M, Gautron A, de Marcken M, Keller M, Hafler D. TLR7 induces anergy in human CD4(+) T cells. Nat Immunol. 2015;16:118-28 pubmed publisher
  273. Kamburova E, Koenen H, van den Hoogen M, Baas M, Joosten I, Hilbrands L. Longitudinal analysis of T and B cell phenotype and function in renal transplant recipients with or without rituximab induction therapy. PLoS ONE. 2014;9:e112658 pubmed publisher
  274. Vogelpoel L, Hansen I, Rispens T, Muller F, van Capel T, Turina M, et al. Fc gamma receptor-TLR cross-talk elicits pro-inflammatory cytokine production by human M2 macrophages. Nat Commun. 2014;5:5444 pubmed publisher
  275. Fernandez C, Amarasena T, Kelleher A, Rossjohn J, McCluskey J, Godfrey D, et al. MAIT cells are depleted early but retain functional cytokine expression in HIV infection. Immunol Cell Biol. 2015;93:177-88 pubmed publisher
  276. Fujita T, Burwitz B, Chew G, Reed J, Pathak R, Seger E, et al. Expansion of dysfunctional Tim-3-expressing effector memory CD8+ T cells during simian immunodeficiency virus infection in rhesus macaques. J Immunol. 2014;193:5576-83 pubmed publisher
  277. Weiskopf D, Angelo M, Bangs D, Sidney J, Paul S, Peters B, et al. The human CD8+ T cell responses induced by a live attenuated tetravalent dengue vaccine are directed against highly conserved epitopes. J Virol. 2015;89:120-8 pubmed publisher
  278. Lim D, Yawata N, Selva K, Li N, Tsai C, Yeong L, et al. The combination of type I IFN, TNF-α, and cell surface receptor engagement with dendritic cells enables NK cells to overcome immune evasion by dengue virus. J Immunol. 2014;193:5065-75 pubmed publisher
  279. Gerna G, Lilleri D, Fornara C, Bruno F, Gabanti E, Cane I, et al. Differential kinetics of human cytomegalovirus load and antibody responses in primary infection of the immunocompetent and immunocompromised host. J Gen Virol. 2015;96:360-9 pubmed publisher
  280. Jansen D, Hameetman M, van Bergen J, Huizinga T, van der Heijde D, Toes R, et al. IL-17-producing CD4+ T cells are increased in early, active axial spondyloarthritis including patients without imaging abnormalities. Rheumatology (Oxford). 2015;54:728-35 pubmed publisher
  281. Cucak H, Vistisen D, Witte D, Philipsen A, Rosendahl A. Reduction of specific circulating lymphocyte populations with metabolic risk factors in patients at risk to develop type 2 diabetes. PLoS ONE. 2014;9:e107140 pubmed publisher
  282. Yu C, Becker C, Metang P, Marches F, Wang Y, Toshiyuki H, et al. Human CD141+ dendritic cells induce CD4+ T cells to produce type 2 cytokines. J Immunol. 2014;193:4335-43 pubmed publisher
  283. Mylvaganam G, Velu V, Hong J, Sadagopal S, Kwa S, Basu R, et al. Diminished viral control during simian immunodeficiency virus infection is associated with aberrant PD-1hi CD4 T cell enrichment in the lymphoid follicles of the rectal mucosa. J Immunol. 2014;193:4527-36 pubmed publisher
  284. Gibbons D, Fleming P, Virasami A, Michel M, Sebire N, Costeloe K, et al. Interleukin-8 (CXCL8) production is a signatory T cell effector function of human newborn infants. Nat Med. 2014;20:1206-10 pubmed publisher
  285. Kudernatsch R, Letsch A, Guerreiro M, Löbel M, Bauer S, Volk H, et al. Human bone marrow contains a subset of quiescent early memory CD8(+) T cells characterized by high CD127 expression and efflux capacity. Eur J Immunol. 2014;44:3532-42 pubmed publisher
  286. Valentin A, McKinnon K, Li J, Rosati M, Kulkarni V, Pilkington G, et al. Comparative analysis of SIV-specific cellular immune responses induced by different vaccine platforms in rhesus macaques. Clin Immunol. 2014;155:91-107 pubmed publisher
  287. Kagina B, Tameris M, Geldenhuys H, Hatherill M, Abel B, Hussey G, et al. The novel tuberculosis vaccine, AERAS-402, is safe in healthy infants previously vaccinated with BCG, and induces dose-dependent CD4 and CD8T cell responses. Vaccine. 2014;32:5908-17 pubmed publisher
  288. Hu H, Eller M, Zafar S, Zhou Y, Gu M, Wei Z, et al. Preferential infection of human Ad5-specific CD4 T cells by HIV in Ad5 naturally exposed and recombinant Ad5-HIV vaccinated individuals. Proc Natl Acad Sci U S A. 2014;111:13439-44 pubmed publisher
  289. Li Z, Li W, Li N, Jiao Y, Chen D, Cui L, et al. γδ T cells are involved in acute HIV infection and associated with AIDS progression. PLoS ONE. 2014;9:e106064 pubmed publisher
  290. Bacher P, Kniemeyer O, Teutschbein J, Thön M, Vödisch M, Wartenberg D, et al. Identification of immunogenic antigens from Aspergillus fumigatus by direct multiparameter characterization of specific conventional and regulatory CD4+ T cells. J Immunol. 2014;193:3332-43 pubmed publisher
  291. Madhavi V, Ana Sosa Batiz F, Jegaskanda S, Center R, Winnall W, Parsons M, et al. Antibody-dependent effector functions against HIV decline in subjects receiving antiretroviral therapy. J Infect Dis. 2015;211:529-38 pubmed publisher
  292. Davey M, Morgan M, Liuzzi A, Tyler C, Khan M, Szakmany T, et al. Microbe-specific unconventional T cells induce human neutrophil differentiation into antigen cross-presenting cells. J Immunol. 2014;193:3704-3716 pubmed publisher
  293. Ohue Y, Kurose K, Mizote Y, Matsumoto H, Nishio Y, Isobe M, et al. Prolongation of overall survival in advanced lung adenocarcinoma patients with the XAGE1 (GAGED2a) antibody. Clin Cancer Res. 2014;20:5052-63 pubmed publisher
  294. Frencher J, Shen H, Yan L, Wilson J, Freitag N, Rizzo A, et al. HMBPP-deficient Listeria mutant immunization alters pulmonary/systemic responses, effector functions, and memory polarization of Vγ2Vδ2 T cells. J Leukoc Biol. 2014;96:957-67 pubmed publisher
  295. Jin J, Zhang W, Wong K, Kwak M, van Driel I, Yu Q. Inhibition of breast cancer resistance protein (ABCG2) in human myeloid dendritic cells induces potent tolerogenic functions during LPS stimulation. PLoS ONE. 2014;9:e104753 pubmed publisher
  296. Tchakoute C, Hesseling A, Kidzeru E, Gamieldien H, Passmore J, Jones C, et al. Delaying BCG vaccination until 8 weeks of age results in robust BCG-specific T-cell responses in HIV-exposed infants. J Infect Dis. 2015;211:338-46 pubmed publisher
  297. Saresella M, Piancone F, Marventano I, La Rosa F, Tortorella P, Caputo D, et al. A role for the TIM-3/GAL-9/BAT3 pathway in determining the clinical phenotype of multiple sclerosis. FASEB J. 2014;28:5000-9 pubmed publisher
  298. Lee Chang C, Bodogai M, Moritoh K, Olkhanud P, Chan A, Croft M, et al. Accumulation of 4-1BBL+ B cells in the elderly induces the generation of granzyme-B+ CD8+ T cells with potential antitumor activity. Blood. 2014;124:1450-9 pubmed publisher
  299. Buggert M, Tauriainen J, Yamamoto T, Frederiksen J, Ivarsson M, Michaelsson J, et al. T-bet and Eomes are differentially linked to the exhausted phenotype of CD8+ T cells in HIV infection. PLoS Pathog. 2014;10:e1004251 pubmed publisher
  300. Chandran P, Keller A, Weinmann L, Seida A, Braun M, Andreev K, et al. The TGF-?-inducible miR-23a cluster attenuates IFN-? levels and antigen-specific cytotoxicity in human CD8? T cells. J Leukoc Biol. 2014;96:633-45 pubmed publisher
  301. Kistowska M, Meier B, Proust T, Feldmeyer L, Cozzio A, Kuendig T, et al. Propionibacterium acnes promotes Th17 and Th17/Th1 responses in acne patients. J Invest Dermatol. 2015;135:110-118 pubmed publisher
  302. Pegram H, Purdon T, van Leeuwen D, Curran K, Giralt S, Barker J, et al. IL-12-secreting CD19-targeted cord blood-derived T cells for the immunotherapy of B-cell acute lymphoblastic leukemia. Leukemia. 2015;29:415-22 pubmed publisher
  303. Ye S, Li Z, Luo D, Huang B, Chen Y, Zhang X, et al. Tumor-derived exosomes promote tumor progression and T-cell dysfunction through the regulation of enriched exosomal microRNAs in human nasopharyngeal carcinoma. Oncotarget. 2014;5:5439-52 pubmed
  304. Kim K, Chung B, Kim B, Cho M, Yang C. The effect of mammalian target of rapamycin inhibition on T helper type 17 and regulatory T cell differentiation in vitro and in vivo in kidney transplant recipients. Immunology. 2015;144:68-78 pubmed publisher
  305. Eisenhardt M, Glässner A, Wolter F, Kramer B, Kokordelis P, Nischalke H, et al. CD27(+)CD56Bright natural killer cells may be involved in spontaneous clearance of acute hepatitis C in HIV-positive patients. AIDS. 2014;28:1879-84 pubmed publisher
  306. Gupta M, Kolli D, Molteni C, Casola A, Garofalo R. Paramyxovirus infection regulates T cell responses by BDCA-1+ and BDCA-3+ myeloid dendritic cells. PLoS ONE. 2014;9:e99227 pubmed publisher
  307. Hong J, Amancha P, Rogers K, Courtney C, Havenar Daughton C, Crotty S, et al. Early lymphoid responses and germinal center formation correlate with lower viral load set points and better prognosis of simian immunodeficiency virus infection. J Immunol. 2014;193:797-806 pubmed publisher
  308. Payne T, Blackinton J, Frisbee A, Pickeral J, Sawant S, Vandergrift N, et al. Transcriptional and posttranscriptional regulation of cytokine gene expression in HIV-1 antigen-specific CD8+ T cells that mediate virus inhibition. J Virol. 2014;88:9514-28 pubmed publisher
  309. Sueur C, Lupo J, Mas P, Morand P, Boyer V. Difference in cytokine production and cell cycle progression induced by Epstein-Barr virus Lmp1 deletion variants in Kmh2, a Hodgkin lymphoma cell line. Virol J. 2014;11:94 pubmed publisher
  310. Jiang B, Wu X, Li X, Yang X, Zhou Y, Yan H, et al. Expansion of NK cells by engineered K562 cells co-expressing 4-1BBL and mMICA, combined with soluble IL-21. Cell Immunol. 2014;290:10-20 pubmed publisher
  311. Bukh I, Calcedo R, Roy S, Carnathan D, Grant R, Qin Q, et al. Increased mucosal CD4+ T cell activation in rhesus macaques following vaccination with an adenoviral vector. J Virol. 2014;88:8468-78 pubmed publisher
  312. Staumont Sallé D, Fleury S, Lazzari A, Molendi Coste O, Hornez N, Lavogiez C, et al. CX?CL1 (fractalkine) and its receptor CX?CR1 regulate atopic dermatitis by controlling effector T cell retention in inflamed skin. J Exp Med. 2014;211:1185-96 pubmed publisher
  313. Deng N, Weaver J, Mosmann T. Cytokine diversity in the Th1-dominated human anti-influenza response caused by variable cytokine expression by Th1 cells, and a minor population of uncommitted IL-2+IFN?- Thpp cells. PLoS ONE. 2014;9:e95986 pubmed publisher
  314. Hebel K, Weinert S, Kuropka B, Knolle J, Kosak B, Jorch G, et al. CD4+ T cells from human neonates and infants are poised spontaneously to run a nonclassical IL-4 program. J Immunol. 2014;192:5160-70 pubmed publisher
  315. Buggert M, Norstr m M, Salemi M, Hecht F, Karlsson A. Functional avidity and IL-2/perforin production is linked to the emergence of mutations within HLA-B*5701-restricted epitopes and HIV-1 disease progression. J Immunol. 2014;192:4685-96 pubmed publisher
  316. Dhodapkar M, Sznol M, Zhao B, Wang D, Carvajal R, Keohan M, et al. Induction of antigen-specific immunity with a vaccine targeting NY-ESO-1 to the dendritic cell receptor DEC-205. Sci Transl Med. 2014;6:232ra51 pubmed publisher
  317. Ye W, Xing Y, Paustian C, van de Ven R, Moudgil T, Hilton T, et al. Cross-presentation of viral antigens in dribbles leads to efficient activation of virus-specific human memory T cells. J Transl Med. 2014;12:100 pubmed publisher
  318. Lanteri M, Diamond M, Law J, Chew G, Wu S, Inglis H, et al. Increased frequency of Tim-3 expressing T cells is associated with symptomatic West Nile virus infection. PLoS ONE. 2014;9:e92134 pubmed publisher
  319. Sereti I, Estes J, Thompson W, Morcock D, Fischl M, Croughs T, et al. Decreases in colonic and systemic inflammation in chronic HIV infection after IL-7 administration. PLoS Pathog. 2014;10:e1003890 pubmed publisher
  320. Chang S, Kohrt H, Maecker H. Monitoring the immune competence of cancer patients to predict outcome. Cancer Immunol Immunother. 2014;63:713-9 pubmed publisher
  321. Kulkarni V, Valentin A, Rosati M, Alicea C, Singh A, Jalah R, et al. Altered response hierarchy and increased T-cell breadth upon HIV-1 conserved element DNA vaccination in macaques. PLoS ONE. 2014;9:e86254 pubmed publisher
  322. Salerno Goncalves R, Rezwan T, Sztein M. B cells modulate mucosal associated invariant T cell immune responses. Front Immunol. 2014;4:511 pubmed publisher
  323. Narita T, Ishida T, Masaki A, Suzuki S, Ito A, Mori F, et al. HTLV-1 bZIP factor-specific CD4 T cell responses in adult T cell leukemia/lymphoma patients after allogeneic hematopoietic stem cell transplantation. J Immunol. 2014;192:940-7 pubmed publisher
  324. Galindo Albarrán A, Ramirez Pliego O, Labastida Conde R, Melchy Pérez E, Liquitaya Montiel A, Esquivel Guadarrama F, et al. CD43 signals prepare human T cells to receive cytokine differentiation signals. J Cell Physiol. 2014;229:172-80 pubmed
  325. Rodriguez M, Loyd C, Ding X, Karim A, MCDONALD D, Canaday D, et al. Mycobacterial phosphatidylinositol mannoside 6 (PIM6) up-regulates TCR-triggered HIV-1 replication in CD4+ T cells. PLoS ONE. 2013;8:e80938 pubmed publisher
  326. Lutwama F, Kagina B, Wajja A, Waiswa F, Mansoor N, Kirimunda S, et al. Distinct T-cell responses when BCG vaccination is delayed from birth to 6 weeks of age in Ugandan infants. J Infect Dis. 2014;209:887-97 pubmed publisher
  327. Wiernik A, Foley B, Zhang B, Verneris M, Warlick E, Gleason M, et al. Targeting natural killer cells to acute myeloid leukemia in vitro with a CD16 x 33 bispecific killer cell engager and ADAM17 inhibition. Clin Cancer Res. 2013;19:3844-55 pubmed publisher
  328. Marin N, Paris S, Rojas M, Garcia L. Functional profile of CD4+ and CD8+ T cells in latently infected individuals and patients with active TB. Tuberculosis (Edinb). 2013;93:155-66 pubmed publisher
  329. Wolff M, Leung J, Davenport M, Poles M, Cho I, Loke P. TH17, TH22 and Treg cells are enriched in the healthy human cecum. PLoS ONE. 2012;7:e41373 pubmed publisher
  330. Qi Y, Operario D, Georas S, Mosmann T. The acute environment, rather than T cell subset pre-commitment, regulates expression of the human T cell cytokine amphiregulin. PLoS ONE. 2012;7:e39072 pubmed publisher
  331. Teirlinck A, McCall M, Roestenberg M, Scholzen A, Woestenenk R, de Mast Q, et al. Longevity and composition of cellular immune responses following experimental Plasmodium falciparum malaria infection in humans. PLoS Pathog. 2011;7:e1002389 pubmed publisher
  332. Karnell J, Karnell F, Stephens G, Rajan B, Morehouse C, Li Y, et al. Mycophenolic acid differentially impacts B cell function depending on the stage of differentiation. J Immunol. 2011;187:3603-12 pubmed publisher
  333. Chen M, Tsai T, Lin Y, Tsai Y, Wang L, Lee M, et al. Antipsychotic drugs suppress the AKT/NF-?B pathway and regulate the differentiation of T-cell subsets. Immunol Lett. 2011;140:81-91 pubmed publisher
  334. Pradier A, Passweg J, Villard J, Kindler V. Human bone marrow stromal cells and skin fibroblasts inhibit natural killer cell proliferation and cytotoxic activity. Cell Transplant. 2011;20:681-91 pubmed publisher
  335. Reeves R, Gillis J, Wong F, Yu Y, Connole M, Johnson R. CD16- natural killer cells: enrichment in mucosal and secondary lymphoid tissues and altered function during chronic SIV infection. Blood. 2010;115:4439-46 pubmed publisher
  336. Oo Y, Weston C, Lalor P, Curbishley S, Withers D, Reynolds G, et al. Distinct roles for CCR4 and CXCR3 in the recruitment and positioning of regulatory T cells in the inflamed human liver. J Immunol. 2010;184:2886-98 pubmed publisher
  337. Brucklacher Waldert V, Steinbach K, Lioznov M, Kolster M, Holscher C, Tolosa E. Phenotypical characterization of human Th17 cells unambiguously identified by surface IL-17A expression. J Immunol. 2009;183:5494-501 pubmed publisher
  338. Trabattoni D, Saresella M, Pacei M, Marventano I, Mendozzi L, Rovaris M, et al. Costimulatory pathways in multiple sclerosis: distinctive expression of PD-1 and PD-L1 in patients with different patterns of disease. J Immunol. 2009;183:4984-93 pubmed publisher
  339. Daubersies P, Ollomo B, Sauzet J, Brahimi K, Perlaza B, Eling W, et al. Genetic immunisation by liver stage antigen 3 protects chimpanzees against malaria despite low immune responses. PLoS ONE. 2008;3:e2659 pubmed publisher
  340. Gurer C, Strowig T, Brilot F, Pack M, Trumpfheller C, Arrey F, et al. Targeting the nuclear antigen 1 of Epstein-Barr virus to the human endocytic receptor DEC-205 stimulates protective T-cell responses. Blood. 2008;112:1231-9 pubmed publisher
  341. Yamada H, Nakashima Y, Okazaki K, Mawatari T, Fukushi J, Kaibara N, et al. Th1 but not Th17 cells predominate in the joints of patients with rheumatoid arthritis. Ann Rheum Dis. 2008;67:1299-304 pubmed
  342. De Fanis U, Mori F, Kurnat R, Lee W, Bova M, Adkinson N, et al. GATA3 up-regulation associated with surface expression of CD294/CRTH2: a unique feature of human Th cells. Blood. 2007;109:4343-50 pubmed
  343. Takeda K, Suzuki T, Shimada S, Shida K, Nanno M, Okumura K. Interleukin-12 is involved in the enhancement of human natural killer cell activity by Lactobacillus casei Shirota. Clin Exp Immunol. 2006;146:109-15 pubmed
  344. Gorski K, Waller E, Bjornton Severson J, Hanten J, Riter C, Kieper W, et al. Distinct indirect pathways govern human NK-cell activation by TLR-7 and TLR-8 agonists. Int Immunol. 2006;18:1115-26 pubmed
  345. Njemini R, Lambert M, Demanet C, Mets T. The effect of aging and inflammation on heat shock protein 27 in human monocytes and lymphocytes. Exp Gerontol. 2006;41:312-9 pubmed
  346. Bratke K, Kuepper M, Bade B, Virchow J, Luttmann W. Differential expression of human granzymes A, B, and K in natural killer cells and during CD8+ T cell differentiation in peripheral blood. Eur J Immunol. 2005;35:2608-16 pubmed
  347. Haddeland U, Sletten G, Brandtzaeg P, Nakstad B. Impaired interleukin (IL)-4-associated generation of CCR4-expressing T cells in neonates with hereditary allergy risk. Clin Exp Immunol. 2005;139:314-22 pubmed
  348. Temmerman S, Pethe K, Parra M, Alonso S, Rouanet C, Pickett T, et al. Methylation-dependent T cell immunity to Mycobacterium tuberculosis heparin-binding hemagglutinin. Nat Med. 2004;10:935-41 pubmed
  349. Singh S, Soe S, Mejia J, Roussilhon C, Theisen M, Corradin G, et al. Identification of a conserved region of Plasmodium falciparum MSP3 targeted by biologically active antibodies to improve vaccine design. J Infect Dis. 2004;190:1010-8 pubmed
  350. Kooijman R, Coppens A. Insulin-like growth factor-I stimulates IL-10 production in human T cells. J Leukoc Biol. 2004;76:862-7 pubmed
  351. Stewart S, Vidali M, Day C, Albano E, Jones D. Oxidative stress as a trigger for cellular immune responses in patients with alcoholic liver disease. Hepatology. 2004;39:197-203 pubmed
  352. Listvanova S, Temmerman S, Stordeur P, Verscheure V, Place S, Zhou L, et al. Optimal kinetics for quantification of antigen-induced cytokines in human peripheral blood mononuclear cells by real-time PCR and by ELISA. J Immunol Methods. 2003;281:27-35 pubmed
  353. Kumar P, Uchil P, Sulochana P, Nirmala G, Chandrashekar R, Haridattatreya M, et al. Screening for T cell-eliciting proteins of Japanese encephalitis virus in a healthy JE-endemic human cohort using recombinant baculovirus-infected insect cell preparations. Arch Virol. 2003;148:1569-91 pubmed
  354. Meloni F, Cascina A, Paschetto E, Marone Bianco A, Morosini M, Pellegrini C, et al. Monocyte chemoattractant protein-1 levels in bronchoalveolar lavage fluid of lung-transplanted patients treated with tacrolimus as rescue treatment for refractory acute rejection. Transplant Proc. 2003;35:1523-6 pubmed
  355. Mascart F, Verscheure V, Malfroot A, Hainaut M, Pierard D, Temerman S, et al. Bordetella pertussis infection in 2-month-old infants promotes type 1 T cell responses. J Immunol. 2003;170:1504-9 pubmed
  356. Cousins D, Lee T, Staynov D. Cytokine coexpression during human Th1/Th2 cell differentiation: direct evidence for coordinated expression of Th2 cytokines. J Immunol. 2002;169:2498-506 pubmed
  357. Roach D, Bean A, Demangel C, France M, Briscoe H, Britton W. TNF regulates chemokine induction essential for cell recruitment, granuloma formation, and clearance of mycobacterial infection. J Immunol. 2002;168:4620-7 pubmed
  358. Bullens D, Rafiq K, Charitidou L, Peng X, Kasran A, Warmerdam P, et al. Effects of co-stimulation by CD58 on human T cell cytokine production: a selective cytokine pattern with induction of high IL-10 production. Int Immunol. 2001;13:181-91 pubmed
  359. Boyaka P, Wright P, Marinaro M, Kiyono H, Johnson J, Gonzales R, et al. Human nasopharyngeal-associated lymphoreticular tissues. Functional analysis of subepithelial and intraepithelial B and T cells from adenoids and tonsils. Am J Pathol. 2000;157:2023-35 pubmed
  360. Ribeiro U, Whiteside T, Basse P, Safatle Ribeiro A, Huneke C, Posner M. Activated natural killer cell tumor retention and cytokine production in colon tumor using a tissue-isolated model. J Surg Res. 1999;82:78-87 pubmed
  361. Koshiba M, Rosin D, Hayashi N, Linden J, Sitkovsky M. Patterns of A2A extracellular adenosine receptor expression in different functional subsets of human peripheral T cells. Flow cytometry studies with anti-A2A receptor monoclonal antibodies. Mol Pharmacol. 1999;55:614-24 pubmed
  362. Braun M, He J, Wu C, Kelsall B. Cholera toxin suppresses interleukin (IL)-12 production and IL-12 receptor beta1 and beta2 chain expression. J Exp Med. 1999;189:541-52 pubmed